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 ABSTRACT 
 
Silicone materials are commonly used for implantable medical devices because 
of their favorable bulk properties. Unfortunately, due to their hydrophobicity, silicones 
have a high affinity for protein adsorption which makes them susceptible to thrombosis. 
In this work, novel PEO-silane amphiphiles [α-(EtO)3Si-(CH2)2-ODMSm-block-PEOn-
OCH3] were developed to act as surface-modifying additives (SMAs) for silicone. Based 
on prior work, the PEO-silane amphiphiles were expected to rapidly migrate to the 
material surface in response to water exposure and result in a hydrophilic and protein-
resistant silicone. These were distinguishable from conventional PEO-silanes due to the 
hydrophobic oligodimethylsiloxane (ODMS) tether which rendered the SMAs 
amphiphilic. They were also unique as SMAs due to their diblock structure and 
crosslinking group (triethoxysilane) to prevent leaching from condensation-cure 
elastomers. 
The PEO-silane amphiphiles were prepared with three PEO lengths (n = 3, 8, and 
16) and compared to analogous non-amphiphilic PEO-silanes (PEO-controls). When 
incorporated into silicone via bulk-modification, the PEO-silane amphiphiles exhibited 
rapid and extensive water-driven restructuring versus silicones modified with the PEO-
controls. Multiple concentrations of each PEO-silane amphiphile were evaluated (5, 10, 
25, 50, and 100 µmol per 1 g silicone) in terms of their ability to confer hydrophilicity 
and protein resistance. From these results, it was determined that PEO length dictates 
restructuring behavior of PEO-silane amphiphiles. Only n = 8 and 16 were able to 
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 achieve substantial hydrophilicity and reduce protein adsorption, but the n = 8 length 
was more effective and maximized protein resistance with concentrations as low as 10 
µmol per 1 g silicone (1.68 wt%). 
Finally, PEO-silane amphiphiles were evaluated in terms of their ability to 
overcome the limitations associated with SMAs (leaching and poor abrasion recovery). 
It was found that triethoxysilane did not prevent leaching of PEO-silane amphiphiles (m 
= 13, n = 8) from silicone in water. However, increasing the ODMS tether length (m = 
30) dramatically reduced leaching and water uptake for both the PEO-silane and diblock 
amphiphiles without impairing restructuring behavior. For all tested SMAs, excellent 
water-driven surface restructuring behavior persisted on bulk-modified silicones after 
material abrasion. 
iii 
 
 DEDICATION 
 
 
 
To Miranda 
I only came to Texas to earn my PhD and I had no intention of finding love, but I 
never thought that I would meet such a wonderful person. Now, I can’t imagine having 
made it through grad school without you. Your love and support over the years have 
been a profound source of encouragement and joy. I can’t imagine another person who is 
more deserving of this dedication. 
 
 
iv 
 
 ACKNOWLEDGEMENTS 
 
I would first like to thank the Sloan Foundation and the National Institute of 
Health. Without their financial support, this work would not have been possible. 
Thanks to my committee members, Dr. Cosgriff-Hernandez, Dr. Maitland, and 
Dr. Ugaz for their guidance during this project. I would like to specially thank my 
committee chair, Dr. Melissa Grunlan. Before even visiting Texas A&M University, I 
knew that I wanted to work on this project, despite having very little knowledge of 
polymer chemistry and limited research experience. Nonetheless, Dr. Grunlan welcomed 
me into her research group and has continued to be an incredibly patient and supportive 
mentor since day one. For that, I will always be grateful. 
I’d also like to thank all of the lab mates I have had the privilege to work with 
over the last five years. Their friendship and help around the lab made my graduate 
school experience far more enjoyable than I ever expected. Thanks especially to those 
students who helped directly on this project and without whom, I would still be 
collecting the data for my second chapter. They include Dr. Melissa Hawkins, John 
Gruetzner, Matthew Hurley, Paige Adair, and Mikayla Barry. Dr. Jeffery Raymond’s 
support and experience were also invaluable for helping us develop and implement 
improved methodologies for characterizing our materials. 
I’d like to give a big thanks to my friends and family. I have been fortunate to 
make some very good friends during my time in Texas. Like me, several of them had 
traveled far from home to attend Texas A&M and were a tremendous source of support 
v 
 
 while I was settling in. I also greatly appreciate the Moore and Coufal families that have 
welcomed me with open arms and made Texas feel like a home away from home. 
Finally, thanks to my mother and father. All of my life they have been a tremendous 
source of love and support that has never faltered, even when I moved across the country 
to embark on this endeavor. 
vi 
 
 TABLE OF CONTENTS 
 
 Page 
ABSTRACT ...................................................................................................................... ii 
DEDICATION .................................................................................................................. iv 
ACKNOWLEDGEMENTS ............................................................................................... v 
TABLE OF CONTENTS ................................................................................................ vii 
LIST OF FIGURES ........................................................................................................... ix 
LIST OF TABLES ............................................................................................................ xi 
CHAPTER I INTRODUCTION ........................................................................................ 1 
1.1 Overview .......................................................................................................... 1 
1.2 Literature Review ............................................................................................. 2 
1.3 Innovation ....................................................................................................... 22 
1.4 Approach ........................................................................................................ 25 
CHAPTER II ENHANCING THE PROTEIN RESISTANCE OF SILICONE VIA 
SURFACE-RESTRUCTURING PEO-SILANE AMPHIPHILES WITH 
VARIABLE PEO LENGTH ............................................................................................ 28 
2.1 Overview ........................................................................................................ 28 
2.2 Introduction .................................................................................................... 29 
2.3 Materials and Methods ................................................................................... 32 
2.4 Results and Discussion ................................................................................... 43 
2.5 Conclusions .................................................................................................... 54 
CHAPTER III PROTEIN RESISTANCE EFFICACY OF PEO-SILANE 
AMPHIPHILES: DEPENDENCE ON PEO-SEGMENT LENGTH AND 
CONCENTRATION IN SILICONE ............................................................................... 56 
3.1 Overview ........................................................................................................ 56 
3.2 Introduction .................................................................................................... 57 
3.3 Materials and Methods ................................................................................... 61 
3.4 Results and Discussion ................................................................................... 65 
3.5 Conclusions .................................................................................................... 71 
vii 
 
 Page 
CHAPTER IV PEO-SILANE AMPHIPHILES ADDRESS THE LIMITATIONS 
ASSOCIATED WITH TRADITIONAL SURFACE-MODIFYING ADDITIVES ........ 73 
4.1 Overview ........................................................................................................ 73 
4.2 Introduction .................................................................................................... 74 
4.3 Materials and Methods ................................................................................... 78 
4.4 Results and Discussion ................................................................................... 85 
4.5 Conclusions .................................................................................................... 95 
CHAPTER V CONCLUSIONS ....................................................................................... 97 
5.1 Conclusions .................................................................................................... 97 
5.2 Future Directions .......................................................................................... 101 
REFERENCES ............................................................................................................... 105 
APPENDIX .................................................................................................................... 129 
 
viii 
 
 LIST OF FIGURES 
 Page 
Figure 1.1. Diagram illustrating the relationship of blood-material reactions 
 and their ultimate dependence on adsorbed protein. .................................. 4 
Figure 1.2.  Grafted PEO chains will be in a brush conformation if the distance 
between neighboring chains (D) is less than the sum of their Flory 
radii (2Rf), otherwise they will be in a “mushroom” regime.................... 16 
Figure 1.3. Examples of methacrylate-based polymers with zwitterionic side 
chains used for thromboresistant coatings. .............................................. 18 
Figure 1.4. PEO-silane amphiphile structure and illustration of water-driven 
surface restructuring mechanism on bulk-modified silicone. .................. 23 
Figure 1.5. Structures of PEO-silane amphiphiles and non-amphiphilic 
analogues evaluated on silicon wafers. .................................................... 26 
Figure 1.6. Structures of amphiphiles evaluated as potential SMAs for 
silicone. .................................................................................................... 27 
Figure 2.1. Structures of PEO-silane amphiphiles, PEO-controls, and siloxane-
control. ...................................................................................................... 31 
Figure 2.2. HR C 1s XPS spectra of silicon wafers grafted with PEO-silane 
amphiphiles (n = 3, 8, and 16) as well as the PEO-control (n = 8) 
and siloxane-control. ................................................................................ 44 
Figure 2.3. Static contact angle (θstatic) of surface-grafted silicon wafers at 0 s 
(dark) and 2 min (light) following placement of water droplet. ............... 48 
Figure 2.4. QCM-D-measured adsorption of human fibrinogen (HF) onto 
silica-coated sensors grafted with the siloxane-control [blue solid 
line], PEO-silane amphiphiles (n = 3, 8, and 16) [dashed lines] and 
PEO-controls (n = 3, 8, and 16) [solid lines]. .......................................... 49 
Figure 2.5. Unmodified silicone and silicones bulk-modified with PEO-silane 
amphiphiles (n = 3, 8, and 16), PEO-controls (n = 3, 8, and 16), 
and the siloxane-control. .......................................................................... 51 
Figure 2.6. Static water contact angles measured over three minutes on bulk-
modified silicone films. ............................................................................ 51 
ix 
 
 Page 
Figure 2.7. Fibrinogen adsorption on bulk-modified silicones as measured by 
fluorescence intensity with confocal microscopy. ................................... 53 
Figure 3.1. PEO-silane amphiphile chemical structure (n = 3, 8, and 16) and 
illustration of water-driven surface restructuring of bulk-modified 
silicone. .................................................................................................... 60 
Figure 3.2. Static water contact angle (θstatic) measured over a 5 min period on 
bulk-modified silicone films. ................................................................... 67 
Figure 3.3. HF adsorption on bulk-modified silicone films as measured by 
fluorescence intensity with confocal microscopy. ................................... 71 
Figure 4.1. Structures of SMA amphiphiles evaluated in this study. ......................... 77 
Figure 4.2. θstatic measured over a five minute period on bulk-modified silicone 
films one week after casting. .................................................................... 87 
Figure 4.3. θstatic measured over a five minute period on freshly exposed 
surface of bulk-modified silicone films after cutting away top layer 
with a razor. .............................................................................................. 88 
Figure 4.4. θstatic measured at “5 min” time point after drop placement on bulk-
modified silicone films during two-week water equilibration study. ....... 89 
Figure 4.5. θstatic measured over a five minute period on bulk-modified silicone 
films after one week curing in air (Initial), two weeks soaked in 
water (Water Equilibrated), and drying under vacuum and elevated 
temperature (Dried). ................................................................................. 90 
Figure 4.6. Film mass loss (left) and mass loss ratio (right) of bulk-modified 
silicone films after soaking in water (above) and DCM (below) for 
two weeks. ................................................................................................ 92 
Figure 4.7. Percent water composition by weight of bulk-modified silicone 
films soaked in water for two weeks. ....................................................... 94 
Figure 5.1. Derivatives of PEO-silane amphiphiles for crosslinking into 
silicone elastomers with different curing chemistries. ........................... 102 
x 
 
 LIST OF TABLES 
 Page 
 
Table 2.1. Surface atomic % compositions by XPS. ................................................. 43 
Table 2.2. Ellipsometry data for grafted surfaces. .................................................... 46 
Table 3.1. Total wt% of PEO-silane amphiphile (i.e. surface-modifying 
additive, SMA) and corresponding wt% of PEO in a modified 
silicone for each total molar concentration of SMA. ............................... 61 
 
 
xi 
 
 CHAPTER I  
INTRODUCTION 
 
1.1 Overview 
Implantable medical devices are often made from materials that are not of 
biological origin. These include metals, ceramics, glasses, polymers, and composite 
materials which may be used in a variety of implants ranging from intraocular lenses to 
artificial joints to heart valves [1]. Such materials can offer several advantages, including 
more desirable mechanical properties and processability, over materials derived from 
living tissue. One of the most significant advantages is that synthetic materials lack 
immunologically recognizable biologic motifs (i.e. antigens) that can trigger an 
immediate or adaptive immune system response [2]. Unfortunately, these materials can 
still trigger certain innate, nonspecific host responses including inflammation [3-6], 
foreign body reaction [7-11], and thrombosis [12]. Many implantable medical devices 
are prone to these reactions which lead to impaired function and adverse consequences 
for patient health. Of those mentioned, thrombosis is a common and costly complication 
for implantable medical devices. The focus of this dissertation henceforth is the 
development of a novel “thromboresistant” biomaterial that addresses this unmet clinical 
need. The following literature review will describe the mechanisms of thrombosis and its 
consequences, current methods for prevention, and its clinical significance. The review 
will also serve as a background before presenting the approach to developing 
thromboresistant coatings which are the focus of this dissertation. 
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 1.2 Literature Review 
1.2.1 Surface-Induced Thrombosis 
The hemostatic mechanism of the human body was described thoroughly by 
Hanson [12]. Briefly, hemostasis is used by the body to arrest bleeding from injured 
blood vessels by clotting blood at the site of injury. Blood coagulation is directed largely 
by small, non-nucleated, disk-shaped cells called platelets that are present in the blood. 
The external surface of the platelet contains membrane bound receptors (i.e. integrins) 
that recognize and interact with damaged tissue. When these receptors are stimulated, 
they activate the rest of the cell, causing it to become “sticky” and change in shape to an 
irregular sphere with spiny pseudopods. The platelet then releases the contents of its 
storage granules that stimulate other nearby platelets, leading to localized platelet 
aggregation and the formation of a fused platelet thrombus. This process is referred to as 
“thrombosis” and is highly effective for quickly arresting local blood flow in response to 
tissue damage. Unfortunately, it can also activate in response to blood-contacting 
medical implants leading to negative consequences. 
As soon as a medical implant makes contact with blood, dissolved proteins in the 
plasma begin to rapidly deposit on the surface via non-specific adsorption (e.g. 
hydrophobic or electrostatic interactions) and influence the subsequent biological 
reaction [2, 13]. Once a protein has bound to the surface, it may provide a site for cell 
attachment, in which case it is referred to as an “adhesion protein”. Fibrinogen is one of 
the best-studied adhesion proteins known to play a major role in platelet adhesion [2, 14-
18]. Hu et al. found that surface-bound fibrinogen undergoes conformational changes 
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 that expose previously hidden epitopes which are then recognized and bound by cell 
integrins [19]. Upon binding to adsorbed fibrinogen, platelets become active and spread 
against the material surface, activating other platelets and thereby advancing thrombosis 
[12]. Additionally, activated platelets release fibrin which polymerizes dissolved and 
surface-bound fibrinogen into fibrin [20]. Fibrin formation strengthens the developing 
thrombus as well as its adhesion to the material [21]. Another important aspect of 
fibrinogen is that it has a higher affinity for hydrophobic surfaces compared to other 
proteins [22]. Unfortunately, many biomaterials (e.g. silicone, polystyrene, 
polyvinylchloride, etc.) are hydrophobic and are prone to fibrinogen adsorption. Even if 
other, less-thrombogenic proteins adsorb to the surface first, they are displaced by 
fibrinogen over time due to its greater surface affinity (i.e. the Vroman effect) [23, 24]. 
This means that an implanted material will likely induce thrombosis unless it specifically 
resists fibrinogen adsorption. 
Blood-material interactions are complex and the factors that influence thrombosis 
extend beyond fibrinogen adsorption and platelet adhesion. As discussed in detail by 
Gorbet and Sefton [20], surface-induced thrombosis may also be heavily influenced or 
induced by the complement system and leukocyte activation even though these are more 
generally associated with inflammation (Figure 1.1). However, the initiation of all of 
these mechanisms, and ultimately thrombosis, is still largely dependent on the adsorption 
of proteins to the material surface. 
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Figure 1.1. Diagram illustrating the relationship of blood-material reactions and 
their ultimate dependence on adsorbed protein. Adapted from [20]. 
 
As discussed by Hanson and Ratner [25], the occurrence of thrombosis on the 
surface of a blood-contacting implant such as a stent, catheter, or ventricular assist 
device (VAD) can lead to several adverse consequences. As the thrombus grows, it can 
obstruct blood flow and cause ischemia of downstream tissue. Segments may break off 
and float downstream as emboli, occluding blood vessels elsewhere or causing 
myocardial infarction (heart attack) or ischemic stroke. Furthermore, thrombus 
formation is believed to provide a substrate that facilitates bacteria adhesion and growth 
which leads to device infection, a major cause of patient mortality [26-29]. For certain 
devices, the presence of a thrombus can also impair functionality. For example, it may 
impede the mechanical motions of a VAD pump, blood flow through a hemodialysis 
catheter, or gas exchange through oxygenators. As such, most blood-contacting medical 
devices are only considered safe when antithrombotic drugs are used. 
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 1.2.2 Antithrombotic Therapies and Complications 
Currently, the most effective strategies for treating and preventing thrombus 
formation are antithrombotic therapies, which make use of anticoagulant drugs such as 
heparin and warfarin. Although the mechanisms by which these drugs work vary, they 
all ultimately serve to inhibit the hemostatic mechanism of the body, thereby preventing 
thrombus formation. A number of studies have demonstrated that such drugs effectively 
reduce the rate of thrombotic complications among patients with blood-contacting 
medical implants [30-36]. Unfortunately, the hemostatic mechanism serves a vital role 
for the body, and impairing it for any length of time puts the patient at risk for other 
serious complications. 
The major complication of any antithrombotic therapy is bleeding. When the 
body is unable to arrest blood flow at the site of injured blood vessels, what otherwise 
may have been a minor or manageable injury can become life-threatening due to 
excessive loss of blood. Levine et al. reviewed a number of studies monitoring the 
occurrences of bleeding complications in patients who had received prosthetic heart 
valves and were treated with various anticoagulant therapies over multiple years [37]. 
Major bleeding complications occurred in as many as 19% of patients with fatalities 
reaching as high as 3%. Higher dosage therapies were associated with higher rates of 
bleeding complications. Rogacka et al. studied the safety of an antithrombotic therapy 
(i.e. aspirin, warfarin, and thienopyridines) for patients with implanted coronary stents 
[38]. During the therapy, six of the 128 patients (5%) developed major bleeding 
complications, four of which occurred in the first month of treatment. Three of the six 
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 patients died, indicating the dangers of bleeding complications. This was confirmed in a 
more recent retrospective review where Guerrouij et al. determined the case-fatality rate 
of 142 patients who suffered warfarin-associated bleeding complications [39]. Of the 
bleeding episodes, 72 (50%) were classified as major bleeds and seven (10%) of those 
patients died. Anticoagulant dosages can be reduced to treat or prevent bleeding, but 
thromboembolic complications are likely to occur if the therapy is not sufficiently 
aggressive [40]. Also, it has been reported that elderly patients are more susceptible to 
thromboembolic complications, which poses a dilemma for physicians considering that 
the risk of bleeding complications from anticoagulants increases with age [41, 42]. 
Clearly, antithrombotic therapies are far from ideal. 
In addition to bleeding risks, anticoagulants are associated with comorbidities. 
For example, it is well-known that heparin usage can result in a condition called heparin-
induced thrombocytopenia (HIT) where platelets become hyperactive and risk of 
thrombosis actually increases [43]. This can lead to occurrences of deep vein 
thrombosis. Other complications resulting from anticoagulants have only recently been 
discovered, as is the case with warfarin. Patients with end-stage renal disease (ESRD) 
undergoing dialysis have a 10-20 times greater risk of mortality from cardiovascular 
events attributed to an increase in vascular calcification versus healthy, age-matched 
individuals [44]. It was also shown in a retrospective study of ESRD patients by Dua et 
al. that warfarin use was associated with significantly higher occurrences of pathologies 
rooted to vascular calcification [45]. Although vascular calcification was originally 
considered a passive process, more recent reports suggest that it’s actually caused by an 
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 upregulation of bone matrix proteins and calcium-regulatory hormones [46]. It is 
possible that this upregulation results from an active vitamin K deficiency caused by 
long-term warfarin use [45, 47].  
 
1.2.3 Thrombotic Complications 
Despite antithrombotic therapies, thrombotic complications still persist in 
patients with blood-contacting medical devices. For example, a recent clinical study of 
the HeartWare® VAD found that 3 of 34 patients (8%) suffered device failure due to 
thrombosis [48]. Similar thrombosis rates have been observed in other VADs. A larger-
scale study (414 patients total) of the HeartMate II® (HMII) VAD found that pump 
thrombosis occurred with 4-6% of patients while 8% suffered ischemic stroke [49]. 
Kirklin et al. examined the cause of HMII failures in the U.S. between 2006 and 2013 
and of 6,910 patients, 659 (10%) suffered device failure [50]. Thrombosis was believed 
to have caused 382 (58%) of those cases which required device replacement (334 
patients [51%]) or resulted in death (45 patients [7%]). According to this study, 
thrombosis should be considered the leading cause of VAD failure. 
Thrombosis is generally less common in coronary stents compared to VADs but 
is still recognized as a major limitation. Stents are typically designed with an 
antiproliferative-drug-eluting coating to help prevent restenosis (not thrombosis). 
Restenosis is an ingrowth of endothelial tissue that may occur around the struts which 
would cause stent narrowing or obstruction and require device replacement [51]. Many 
clinical studies have reported low thrombotic complication rates (< 2%) for up to one 
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 year in patients with drug-eluting stents (DESs) while undergoing antithrombotic 
therapy [51-54]. A large-scale study of 15,147 patients undergoing dual antiplatelet 
therapy after stent implantation found that only 1.0% suffered stent thrombosis within 
one year of the surgery [55]. Unfortunately, by preventing restenosis, the struts of the 
DES are left exposed to blood so that despite the seemingly low day-to-day risk of 
surface-induced thrombosis, that risk persists for many years after implantation [56-62]. 
This represents a significant issue considering the lethal implications of stent thrombosis 
[63-68]. Notably, it is believed that stent thrombosis may lead to heart attack and/or 
death in as many as 90% of cases [69]. 
Hemodialysis catheters represent a blood-contacting implant that is highly 
susceptible to thrombosis and they will be the focus of the remainder of this review. 
Catheters are heavily relied upon for hemodialysis of patients with ESRD [70] and for 
cancer patient chemotherapy [71] despite the fact that thrombosis remains a common 
complication [72-75]. Thrombosis can occur within hours of device insertion or after 
long periods of successful usage [76]. Studies have reported thrombotic occlusion in 30 
– 40% of catheter patients which causes dysfunction by preventing adequate blood flow 
[76, 77]. In addition to dysfunction and the associated healthcare costs [78], catheter 
thrombosis may have lethal consequences for dialysis patients. As mentioned earlier, it 
can lead to embolic complications including ischemic stroke and heart attack [79, 80]. 
Catheter thrombosis is also believed to facilitate infection, the leading cause of patient 
mortality [26-29]. This is particularly alarming considering that infection-attributable 
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 deaths of dialysis patients are 100 times more common than that of the general 
population [81]. 
Thrombosis may occur on the intraluminal or extraluminal surfaces of catheters. 
Extraluminal thrombosis is the most common, with incidence on nearly all implanted 
catheters [27, 82]. It typically begins near where the catheter enters the vein and 
facilitates the formation of a “fibrin sheath” that can grow to close off the tip [83]. Fibrin 
sheath formation begins within hours of device insertion and may cover as much as 80 to 
100% of the catheter length within 7 days [83, 84]. In addition to preventing blood flow 
through the catheter, fibrin sheath formation can also reduce blood flow around the 
catheter by as much as 60%, which also increases platelet adhesion [85]. This reduced 
blood flow causes a complication known as deep vein thrombosis which is associated 
with swelling and tenderness of tissue along the affected vein [71]. It occurs in 1 to 5% 
of patients with catheters [86-89], and can be dangerous if left untreated. Despite its high 
incidence, the presence of a fibrin sheath often goes unnoticed prior to removal as it can 
only otherwise be detected when adverse symptoms occur. 
Intraluminal catheter thrombosis is much more likely to impair function and is 
combatted with use of locking solutions. Typically, this involves the insertion of a 
concentrated heparin solution (or “lock”) into the lumens up to the very tip of the 
catheter after dialysis and is intended to prevent intraluminal clot formation between 
dialysis sessions [74, 90-92]. It has been found that these solutions leak from the lumen 
tip [93-95], administering heparin systemically which results in HIT and bleeding 
complications [96-98]. Another anticoagulant, trisodium citrate (often referred to as 
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 “sodium citrate”) has been used for locks instead of heparin because it has a lower risk 
of producing this systemic effect [95, 99]. While trisodium citrate is generally not as 
effective at inhibiting hemostasis compared to heparin [100, 101], the two anticoagulants 
have been shown to preserve catheter efficacy equally well in clinical studies [92, 99-
101]. However, regardless of the locking solution, leaking will occur and most catheters 
eventually become dysfunctional [102]. With leaking, the catheter tip becomes 
particularly susceptible to thrombosis and may produce thromboemboli after resuming 
hemodialysis [80, 95]. 
 
1.2.4 Improving Material Thromboresistance 
The persistence of thrombotic complications despite antithrombotic therapies has 
motivated the development of alternative materials for improving the safety of catheters 
and other medical implants. As thrombosis is largely induced by biological interactions 
with the device surface, one solution is to use materials with surface properties that resist 
or inhibit thrombosis (thromboresistance). Unfortunately, material selection for medical 
devices such as catheters is largely based on bulk properties rather than surface 
properties. Silicones and polyurethanes are widely used for catheters because of their 
favorable mechanical strength and flexibility [103, 104], despite inherent hydrophobicity 
which makes them susceptible to surface-induced thrombosis [105, 106]. Ideally, 
thromboresistance could be achieved through surface modification that would preserve 
the bulk properties [107]. In addition, a clinically and commercially feasible approach 
must achieve complete and uniform surface modification, be stable under in vivo 
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 conditions, be broadly applicable to medical device materials, and consist of a process 
that is facile and reproducible [108]. To date, no such strategy has met all of these 
requirements, but some of the more successful surface modification strategies to achieve 
thromboresistance will now be reviewed. 
 
1.2.4.1 Heparin Coatings 
A well-established approach to reduce material thrombogenicity has been to 
apply heparin coatings to blood-contacting medical devices [108]. Although the coating 
methods vary, they each aim to prevent thrombosis through active inhibition of 
hemostatic mechanisms at the material surface [109, 110]. Because this effect is 
localized to the implant site, it theoretically permits the use of the anticoagulant without 
typical risks associated with systemic therapy. Over 200 heparin-coated medical devices 
have received FDA approval [111], but there are serious concerns regarding the efficacy 
and safety of heparin coatings. It has been demonstrated that heparin-coated surfaces 
exhibit leaching, non-uniform distribution, and reduced anti-coagulant activity versus 
unbound heparin [112]. It has also been found that surface-bound heparin chains, due to 
their inherent negative charge, may in fact promote protein adsorption and subsequent 
thrombosis [113]. This may explain the current lack of evidence demonstrating that the 
patency of blood-contacting catheters is statistically improved with heparin-coatings. 
In the case of pediatric central venous catheters, no study has conclusively shown 
that heparin-coatings reduce catheter-related thrombosis or improve patency [114]. Also, 
a number of clinical studies have compared hemodialysis catheters with and without 
11 
 
 heparin coatings and observed no statistical difference in dysfunction rates [115-117]. 
Furthermore, heparin coatings are known to likewise cause HIT [118-120]. The use of 
heparin coatings to prevent surface-induced thrombosis is therefore difficult to justify, 
especially considering the complexity and cost of heparin coating application [109, 110]. 
 
1.2.4.2 Passive Coatings 
An attractive alternative to “bioactive” heparin coatings are materials that resist 
biological interactions. As discussed earlier, the first stage of surface-induced 
thrombosis occurs with the adsorption of plasma proteins. Thus a surface that resists 
protein adsorption should minimize thrombosis. “Passivation” refers to a strategy which 
achieves thromboresistance through protein resistance. 
An early passivation strategy was based on pre-adsorbing a non-adhesion protein 
to a surface before implantation. Albumin, the most abundant protein in blood, doesn’t 
present any epitopes recognized by platelets when bound to a surface [121]. Thus, it was 
hypothesized that a device surface preadsorbed with albumin before implantation should 
block underlying adsorption sites and prevent subsequent platelet interactions [122]. 
Albumin coatings have been evaluated to improve the thromboresistance of devices such 
as artificial kidneys and blood oxygenators [122, 123]. Unfortunately, their efficacy was 
only temporary and they lost the ability to prevent thrombosis within hours of 
implantation. This is attributed to the Vroman effect in which physically adsorbed 
albumin is gradually displaced by proteins with higher surface affinity including 
fibrinogen [2]. Chemical modifications have been used to prevent albumin displacement 
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 [121], but this does not prevent the protein from denaturing over time. Denatured 
albumin forms a substrate to which adhesion proteins can adsorb [124]. Therefore, 
regardless of the immobilization technique for albumin coatings, adsorption of adhesion 
proteins will eventually occur followed by thrombosis. 
As with fibrinogen and albumin, plasma proteins generally have a strong affinity 
for hydrophobic materials [125]. Non-polar regions on protein are attracted to the 
material and the interaction is thermodynamically favorable as adsorption reduces the 
high interfacial energy between the hydrophobic surface and aqueous (biological) 
environment [126, 127]. Therefore, enhancing surface hydrophilicity (i.e. wettability) 
can also passively improve biomaterial thromboresistance. A popular method to achieve 
hydrophilicity is the creation of a hydrogel at the surface. Hydrogel coatings are 
comprised of water-soluble, crosslinked polymers which are able to retain large amounts 
of water without dissolving [121]. Under aqueous (biological) conditions, they minimize 
interfacial energy which makes them highly resistant to protein adsorption and cell 
adhesion [128]. A number of studies confirmed this by demonstrating a decrease in 
thrombus formation on hydrogel surfaces that decreased with higher water content [129, 
130]. Despite their resistance to protein adsorption, hydrogel coatings can still have 
adverse consequences. Although the mechanism is unclear, hydrogels have also been 
associated with platelet activation. It has been observed that surfaces with high water 
content can cause destruction of circulating platelets which results in platelet 
microemboli [131] and the associated medical complications [132]. Furthermore, it has 
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 been shown that hydroxyl (-OH) or amine (-NH3) polar groups commonly present in 
hydrogels can induce complement activation and inflammation [4]. 
 
1.2.4.3 PEO Coatings 
One of the most popular hydrophilic polymers for surface passivation, and 
largely considered as a gold standard, is poly(ethylene oxide) (PEO) [or poly(ethylene 
glycol) (PEG) depending on the polymerization method]. PEO has been incorporated 
onto surfaces by physical adsorption [133-138] or chemical grafting techniques [139-
153] and has been shown to dramatically reduce protein adsorption and thrombogenicity 
in vitro. The mechanisms of PEO’s exceptional protein resistance have been widely 
studied. In addition to the aforementioned low interfacial energy associated with water-
soluble polymers, theoretical models have demonstrated that extended and highly 
flexible PEO chains sterically repel protein from the surface [154-157]. This effect 
largely results from a resistance to the thermodynamically unfavorable loss in 
configurational entropy that occurs as PEO chains are compressed by approaching 
protein. PEO coatings on hydrophobic materials can also prevent protein adsorption 
simply by blocking underlying binding sites [158]. More advanced molecular 
simulations have also revealed that via hydrogen bonding, grafted PEO chains tightly 
associate with local water molecules and create a “hydration layer” that physically 
excludes protein and other macromolecules [159].  
In order to be effective, the PEO must be present at the surface in an extended 
“brush” conformation [144] so as to provide the most surface coverage. The brush 
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 regime is achieved when the distance between neighboring chains (D) is less than the 
sum of their Flory radii (D < 2Rf) (Figure 1.2) and is indicative of high graft density (σ, 
σ = 4π/D2) [160]. Efficacy is therefore largely dependent on PEO chain spacing (D) and 
molecular weight (MW ∝ Rf). With less efficient PEO incorporation strategies, high 
MW chains (MW >> 3,500 g mol-1) can be used to optimize material protein resistance 
[149, 150, 161-163]. However, Prime and Whitesides were also able to attain excellent 
protein resistance with PEO oligomers (MW ≈ 50 – 750 g mol-1) [142]. They attributed 
the results to their use of a highly efficient self-assembled monolayers (SAMs) grafting 
strategy that resulted in closely packed PEO chains (low D, high σ). The importance of 
graft density in dictating PEO protein resistance has since been confirmed in additional 
studies [144, 164, 165]. Interestingly, with PEO SAMs it has been observed that the 
graft density can become too high, at which point the protein resistance is reduced [166-
168]. It is believed that when neighboring PEO chains are packed too tightly, water is 
excluded which impairs formation of an effective hydration layer [159]. 
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Figure 1.2. Grafted PEO chains will be in a brush conformation if the distance 
between neighboring chains (D) is less than the sum of their Flory radii (2Rf), 
otherwise they will be in a “mushroom” regime (Reprinted with permission from 
[160], Copyright 2015 by John Wiley and Sons). 
 
Despite promising in vitro evaluations of PEO coatings, their performance in 
vivo has been disappointing or inconsistent [169-171]. For example, Park and coworkers 
evaluated a variety of common biomaterials on cardiovascular devices in vivo and 
obtained mixed results [169]. They found that grafting PEO onto nitinol stents reduced 
thrombus formation by more than 85% in porcine shunt experiments. However, PEO on 
vascular grafts of silicone, polyethylene, and Teflon in canine shunts only reduced 
platelet adhesion by 35% versus uncoated controls. They also implanted heart valves 
made with PEO-coated and uncoated Dacron into pigs and observed no improvement of 
thromboresistance in vivo. 
While the reason for the poor success of PEO coatings remains unclear, several 
groups have attributed this to the postulated oxidative degradation of PEO under 
biological conditions [172-176]. However, Browning et al. recently examined the 
stability of PEO-diacrylamide hydrogels implanted in rats for three months and observed 
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 no significant loss in mechanical strength [177]. This indicated that contrary to popular 
claim, little to no PEO degradation actually occurred in vivo. A more likely explanation 
for poor PEO coating performance is their inability to reduce fibrinogen adsorption 
sufficiently to prevent platelet adhesion. It has been reported that adsorption levels must 
be less than 5 ng/cm2 [178]. When PEO is grafted at the surface of polymeric 
biomaterials, it will also be prone to thermodynamically-driven migration into the bulk 
of the material (i.e. hydrophobic recovery) [107], particularly during storage in air [179]. 
This effectively would reduce graft density and efficacy over time. Therefore, despite 
their proven efficacy in improving material thromboresistance [176], PEO coatings do 
have significant shortcomings that limit their potential. 
 
1.2.4.4 Zwitterionic Coatings 
Another passive approach to improving material thromboresistance has been to 
design coatings that mimic the inert surface chemistries of the natural vascular 
endothelium [180]. Taken into consideration is the fact that mammalian cell membranes 
are largely comprised of a phospholipid bilayer. The polar head group of the 
phospholipid, which is presented at the membrane surface, contains a closely associated 
positively charged phosphate and negatively charged choline, resulting in an overall 
neutral charge and referred to as a zwitterion. Researchers have attempted to mimic this 
with polymeric coatings containing zwitterions such as phosphobetaine, sulfobetaine, 
carboxybetaine (Figure 1.3), and amino acids [174]. 
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Figure 1.3. Examples of methacrylate-based polymers with zwitterionic side chains used 
for thromboresistant coatings. 
 
Zwitterionic coatings have been incorporated onto a variety of materials to 
dramatically reduce protein adsorption and cell adhesion [181-197]. Similar to PEO, 
grafted zwitterionic polymers are density-dependent [194] and prevent protein 
adsorption through formation of a hydration layer. For zwitterions, the hydration layer is 
more tightly bound by electrostatic interactions as opposed to hydrogen bonding with 
PEO [159, 198]. It could therefore be inferred from this that zwitterions are more 
repellant towards protein than PEO. However, in comparing the two at similar graft 
chain length and density, Feng and coworkers demonstrated that PEO and zwitterionic 
coatings achieved similar protein resistance [195, 196]. As with PEO, there is a lack of 
evidence supporting the efficacy of zwitterionic coatings’ ability to prevent thrombosis 
in vivo [176, 199, 200].  
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 1.2.4.5 Limitations of Material Modification Strategies 
The limitations of passive coatings using direct surface modification strategies 
are largely related to the chosen application technique. Physical adsorption techniques 
are generally simple (e.g. dip-coating), but the attractive forces of the secondary 
interactions are weak and immobilized polymers may be removed from the surface over 
time [201]. Thus, such coatings are not appropriate for blood-contacting implants 
intended for long-term use. Surface-grafting techniques result in polymers covalently 
attached to the substrate thereby improving potential long-term stability. These polymers 
can either be synthesized before attachment (“graft-to”) or formed by polymerizing 
monomers directly from the substrate (“graft-from”) [160]. However, both of these 
techniques can be quite complex. For example, a graftable substrate must contain 
functional groups or initiators to which the polymers can covalently attach or grow from, 
respectively. Many biomaterials lack these, so the surface must be pre-treated 
accordingly with additional steps. High grafting efficiency may also be difficult to 
achieve with “graft-to” techniques. Substrate attachment by free chains is inhibited due 
to steric blocking of attachment sites by other chains [121]. This can result in low-graft-
density coatings with poor protein resistance. Thermodynamically poor solvents may 
diminish this effect by reducing the grafting chains’ Rf [121], but this approach may 
result in dissolution or swelling of polymer substrates. 
PEO and zwitterionic polymers have been mostly studied when surface-grafted 
on model substrates (e.g. glass [145, 146, 184], silicon [151-153, 194, 195], and gold 
[140-142, 186-192]). On model substrates, surface-grafted PEO and zwitterionic 
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 polymers are highly protein resistant. However, their efficacy may change considerably 
when incorporated into polymeric materials. As discussed earlier, surface-grafted 
polymeric materials can undergo hydrophobic recovery which reduces graft-chain 
density over time [107]. Alternatively, PEO has been incorporated via bulk covalent 
attachment [161, 163, 201-205] or physical blending [162, 206-209] strategies. In order 
to reduce protein adsorption, bulk-modified systems must undergo microphase 
restructuring to create a surface that is sufficiently dense in PEO. An inability to 
properly “surface restructure” could explain the poor performance of PEO in some bulk-
modified biomaterials [161, 202, 205]. 
 
1.2.4.6 Surface-Modifying Additives 
Toward the goal of optimizing PEO surface restructuring in bulk-modified 
systems, surface-modifying additives (SMAs) have been studied [210]. In this approach, 
a small concentration (< 5 wt%) of SMA is mixed into a base polymer and high PEO 
surface coverage can be achieved without any adverse effects to the bulk-properties 
[108]. Most frequently, SMAs are designed as amphiphilic tribock copolymers (A-B-A), 
the centers of which are a hydrophobic chain (B) capped on both ends by identical, 
hydrophilic chains (A). When blended into a base polymer, SMAs migrate to the 
material surface driven by the minimization of interfacial energy during or after 
fabrication. The hydrophilic component of the SMA improves surface wettability to 
reduce protein adsorption. The hydrophobic component physically anchors the additive 
into the base polymer to prevent leaching.  
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 Tsai et al. tested the thromboresistance of polyvinylchloride (PVC) modified 
with a SMA (1 wt%) composed of hydrophobic polydimethylsiloxane (PDMS; MWPDMS 
≈ 2,000 g mol-1) and hydrophilic polycaprolactone (PCL; MWPCL ≈ 2,000 g mol-1) (PCL-
PDMS-PCL) [211]. When compared to unmodified PVC, they observed that the 
thrombogenicity of PVC with SMA was significantly reduced. To improve the protein 
resistance of polyurethane (PU), Tan and coworkers recently developed a PEO-PU-PEO 
(MWPEO ≈ 550 g mol-1; MWPU ≈ 4750 g mol-1) SMA that was found to be more effective 
than surface-grafted PEO (“graft-to” approach) [176, 209]. They hypothesized that 
migration of the SMA to the surface created a denser PEO layer than what was attainable 
by surface grafting. Commercially available triblock copolymers consisting of 
poly(propylene oxide) (PPO) and PEO (PEO-PPO-PEO, Pluronics®) have also been 
shown to be effective as additives for improving material thromboresistance [207, 208]. 
Zwitterionic SMA oligomers have been reported [212, 213], but their poor solubility in 
aprotic solvents makes blending difficult and has limited their commercial use [214]. In 
clinical trials, SMAs have successfully reduced thrombotic complications on several 
blood-contacting medical devices including catheters [215, 216], vascular grafts [217], 
and cardiopulmonary bypass circuits [218, 219].  
Despite its success, current SMA technology has some significant shortcomings 
that have been a source of criticism [108]. Restructuring of SMAs to the surface can be 
very slow or may not occur after fabrication. Thus, accidental abrasion of the device can 
remove surface-present SMAs and compromise protein resistance. Also, leaching of 
SMAs may occur, particularly with low molecular weight chains. Similar to physically 
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adsorbed polymers, SMAs are not covalently attached to the base polymer and can be 
removed during implantation. Safe usage of SMA-modified materials therefore requires 
additional processing steps to remove the leachable additive species. Otherwise, leaching 
could adversely affect patient health and reduce protein resistance as SMAs are 
gradually lost. 
1.3 Innovation 
Surface passivation strategies, including those based on PEO, have failed to 
produce thromboresistant materials. As noted earlier (1.2.4), silicones are widely utilized 
for blood-contacting medical devices (e.g. catheters) despite their exceptional 
hydrophobicity which causes thrombosis. In previous work by Grunlan and coworkers, 
new PEO-silane amphiphiles were evaluated as SMAs for silicones [220]. As shown in 
Figure 1.4, these PEO-silane amphiphiles consist of three main components: (1) a 
hydrophilic PEO segment of length n, (2) a crosslinkable triethoxysilane group, and (3) a 
hydrophobic oligodimethylsiloxane (ODMS) tether of length m. Their efficacy as SMAs 
in a medical-grade silicone was shown to be dependent on siloxane tether length. 
Specifically, it was demonstrated that silicone wettability increased and protein 
resistance improved when it was modified with PEO-silane amphiphiles (n = 8) 
consisting of longer siloxane tethers (m = 0 < m = 4 < m = 13). A subsequent study 
verified that concentrations as low as 1 and 5 wt% of PEO-silane amphiphile (m = 13, n 
= 8) were effective in reducing protein adsorption [221]. Furthermore, it was 
demonstrated that the SMAs underwent water-driven restructuring which resulted in a 
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 PEO-rich silicone surface in response to aqueous exposure [222]. In the present work, 
towards improving their efficacy as SMAs, key changes were systematically evaluated: 
(1) PEO-segment length (n), (2) SMA concentration, (3) siloxane tether length (m), (4) 
omission of the crosslinkable group, and (5) a triblock architecture (i.e. PEOn-ODMSm-
PEOn). The corresponding changes in water-driven surface restructuring and protein 
resistance were likewise evaluated.  
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Figure 1.4. PEO-silane amphiphile structure and illustration of water-driven 
surface restructuring mechanism on bulk-modified silicone. 
 
PEO-silanes have been reported by Chen and coworkers for use as additives to 
improve silicone protein resistance [201, 202]. In their work, PEO was complexed 
directly with triethoxysilane so that the polymer would chemically crosslink within a 
condensation-cure silicone elastomer and prevent leaching. However, these PEO-silanes 
were not explicitly designed to be SMAs and it is hypothesized that they did not rapidly 
migrate to the material surface due to their poor mobility within the hydrophobic silicone 
network. The PEO-silane amphiphiles described in this work differ from those non-
amphiphilic PEO-silanes in that the PEO is separated from the triethoxysilane by a 
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 flexible, hydrophobic siloxane tether. The siloxane tether serves to improve the 
miscibility and mobility of PEO within the silicone so it can more effectively migrate to 
the surface as a SMA. PEO-silane amphiphiles are also innovative because they are a 
diblock (A-B) structure, not triblock (A-B-A) like most SMAs. It is hypothesized that 
this reduces solubility and subsequent leaching in aqueous environments as only one 
(rather than two) water-soluble component (A) is present. 
More recent findings have demonstrated that increasing the length of the siloxane 
tether beyond m = 13 does not impair PEO-silane amphiphile restructuring [223] and it 
could foreseeably benefit the SMAs for two reasons. Firstly, a larger hydrophobic 
segment should prevent leaching of uncrosslinked SMAs by simultaneously increasing 
chain affinity for the base silicone and reducing solubility in water. Secondly, it could 
obviate the need for a crosslinking group (triethoxysilane) if leaching is sufficiently 
reduced. This would simplify synthesis considerably and could permit use of the 
amphiphiles in a greater variety of silicone elastomers regardless of crosslinking 
chemistry. 
As SMAs, the PEO-silane amphiphiles address many of the shortcomings 
associated with passive coating strategies (described in 1.2.4.5). However, they also 
overcome the limitations historically associated with SMAs [108]. As demonstrated in 
the presented work, PEO-silane amphiphiles achieve rapid water-driven migration to the 
surface of silicone. This makes them highly effective in reducing protein adsorption and 
in the case of material abrasion, ensures that the PEO-silane amphiphiles can quickly 
migrate from the bulk to replenish PEO surface coverage. By incorporating 
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triethoxysilane or increasing the siloxane tether length, undesirable leaching of PEO-
silane amphiphiles is also reduced. 
1.4 Approach 
As previously discussed (1.2.4.3), the MW of surface-grafted PEO can 
significantly influence its protein resistance by affecting chain conformation. However, 
its size may also affect the efficacy of PEO SMAs [208, 209]. As the length of PEO is 
increased, it becomes increasingly immiscible in silicone and is faced with a greater 
steric challenge in reaching the material surface. However, short lengths may not be able 
to achieve the high PEO surface coverage necessary for effective protein resistance. In 
attempt to optimize their performance, PEO-silane amphiphiles were prepared with 
multiple PEO-segment lengths (n = 3, 8, and 16) while the siloxane length was kept 
constant (m = 13). 
As mentioned earlier (1.2.4.5), novel passive coatings are typically screened on 
model substrates such as gold, glass, and silicon before they are applied to polymeric 
biomaterials. Model substrates are planar and absent surface restructuring effects which 
permits excellent coating characterization and use of highly sensitive protein adsorption 
measurement techniques (e.g. quartz crystal microbalance [QCM] and surface plasmon 
resonance [SPR]). PEO-silane amphiphiles were similarly evaluated by grafting onto 
silicon wafers. Analogous non-amphiphilic PEO-silanes were also prepared where the 
PEO was separated from the grafting group by a short propyl spacer (Figure 1.5). This 
permitted evaluation of the siloxane tether’s effect on the inherent protein resistance of 
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PEO absent surface restructuring effects. Next, PEO-silane amphiphiles and their non-
amphiphilic analogues were incorporated into a medical-grade, condensation-cure 
silicone via bulk-modification as illustrated in Figure 1.4. Water-driven surface 
restructuring and protein resistance were then evaluated. As the silicone is used for 
actual blood-contacting medical devices, these results were considered more significant 
than those of the surface-grafted silicon wafers. By comparing the results, the prudence 
of using a model substrate to screen SMAs for protein resistance was also evaluated. 
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Figure 1.5. Structures of PEO-silane amphiphiles and non-amphiphilic analogues 
evaluated on silicon wafers. Lengths of PEO included n = 3, 8, and 16. 
In a subsequent study, multiple molar concentrations of the PEO-silane 
amphiphiles in silicone were prepared. Again, water-driven surface restructuring and 
protein resistance were evaluated at each PEO-segment length and concentration. This 
distinguished whether observed differences in additive performance were due to PEO 
chain length or rather differences in PEO weight content. Furthermore, these results 
helped to estimate the minimum concentration of PEO-silane amphiphile required to 
improve silicone protein resistance. In this study, bacterial growth was also measured on 
the bulk-modified silicones to evaluate their ability to resist infection. 
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Finally, the PEO-silane amphiphiles were compared to analogous diblock 
amphiphiles (PEOn-ODMSm) in an effort to understand how covalent crosslinking or 
lack-thereof influences their performance. Triblock amphiphiles were also prepared that 
were representative of more traditional SMA structure for comparison. The structures of 
these amphiphiles are illustrated in Figure 1.6. In order to estimate their propensity for 
leaching, bulk-modified silicone films were conditioned in water and evaluated for 
resulting mass loss, surface restructuring, and water-uptake. A longer siloxane tether (m 
= 30) was also tested with each amphiphile to determine if it could reduce SMA leaching 
in water. The results of this study were used to determine which structure of PEO-
ODMS block copolymers was best-suited for use as a silicone SMA. 
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Figure 1.6. Structures of amphiphiles evaluated as potential SMAs for silicone. 
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CHAPTER II  
ENHANCING THE PROTEIN RESISTANCE OF SILICONE VIA SURFACE-
RESTRUCTURING PEO-SILANE AMPHIPHILES WITH VARIABLE PEO 
LENGTH* 
2.1 Overview 
Silicones with superior protein resistance were produced by bulk-modification 
with poly(ethylene oxide) (PEO)-silane amphiphiles that demonstrated a higher capacity 
to restructure to the surface-water interface versus conventional non-amphiphilic PEO-
silanes. The PEO-silane amphiphiles were prepared with a single siloxane tether length 
but variable PEO segment lengths: α-(EtO)3Si(CH2)2-oligodimethylsiloxane13-block-
poly(ethylene oxide)n-OCH3 (n = 3, 8, and 16). Conventional PEO-silane analogues (n = 
3, 8, and 16) as well as a siloxane tether-silane (i.e. no PEO segment) were prepared as 
controls. When surface-grafted onto silicon wafer, PEO-silane amphiphiles produced 
surfaces that were more hydrophobic and thus more adherent towards fibrinogen versus 
the corresponding PEO-silane. However, when blended into a silicone, PEO-silane 
amphiphiles exhibited rapid restructuring to the surface-water interface and excellent 
protein resistance whereas the PEO-silanes did not. Silicones modified with PEO-silane 
amphiphiles of PEO segment lengths n = 8 and 16 achieved the highest protein 
resistance. 
   ______________________
*Reprinted with permission from “Enhancing the protein resistance of silicone via surface-
restructuring PEO-silane amphiphiles with variable PEO length” by Rufin, M.A., et al., 2015. J 
Mater Chem B. 3(14), p. 2816-2825, Copyright 2015 by The Royal Society of Chemistry. 
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 2.2 Introduction 
Silicones, particularly silica-reinforced, crosslinked polydimethylsiloxane 
(PDMS), are widely used for medical, marine and industrial applications. These include 
blood-contacting devices (e.g. hemodialysis catheters, catheter balloons and cardiac 
pacing leads) [224-226] and marine coatings [227]. Unfortunately, as a result of their 
extreme hydrophobicity, the performance of silicones is severely limited by poor 
resistance to biomolecules such as proteins [228, 229]. For example, in the case of 
blood-contacting devices, the non-specific adsorption of plasma proteins is considered 
the first step of thrombosis and even infection [12, 26, 27]. Various modifications have 
been utilized to hydrophilize silicones in order to reduce protein adsorption, including 
physical, chemical and combined approaches [230-234]. 
Modification with poly(ethylene oxide) (PEO; or poly[ethylene glycol] [PEG]) 
represents arguably the most widely utilized method for enhancing hydrophilicity and 
protein resistance [147, 208, 235-238]. The exceptional protein resistance of PEO is 
attributed to its hydrophilicity and hydration, as well as its configurational mobility 
[154-157]. The biocompatibility [239] and recently demonstrated in vivo oxidative 
stability [177] of PEO contributes to its widespread use. Notably, the protein resistance 
of PEO has largely been assessed for chains surface-grafted onto physically stable 
substrates such as gold [140-142], silicon [151-153], and glass [145, 146]. For these 
“model PEO surfaces,” PEO chains are maintained at the surface irrespective of the 
environment (i.e. air versus water). In contrast, PEO chains incorporated into silicones 
are subject to surface reorganization upon exposure to a different environment [240]. 
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 This process has been studied mainly in terms of hydrophobic recovery (i.e. loss of 
hydrophilicity with exposure to air) such as that observed for plasma treated silicones 
[241]. This behavior is attributed to the low surface energy of silicones [242, 243], 
coupled with their high chain flexibility [244, 245]. For example, hydrophobic recovery 
has been observed for PEO-modified silicones formed by bulk crosslinking with 
triethoxysilylpropyl PEO monomethyl ether [(EtO)3Si(CH2)3-(OCH2CH2)x-OCH3] [201, 
202] as well as allyl PEO monomethyl ether [CH2=CHCH2-(OCH2CH2)x-OCH3] [246]. 
Hydrophobic recovery is also observed for surface-grafted PEO chains such as those 
prepared with allyl PEO monomethyl ether [147, 246]. However, since biofouling events 
such as protein adsorption occur in an aqueous environment, the rapid and substantial 
surface restructuring of PEO to the surface-water interface is of critical importance. 
Towards the goal of enhancing the protein resistance of silicones, we sought to 
improve the capacity of PEO to migrate to the surface-water interface by altering its 
molecular structure. Previously, we reported PEO-silane amphiphiles prepared with a 
siloxane tether of varying lengths (m) separating the PEO segment from the 
crosslinkable ethoxy silane groups [α(EtO)3-Si(CH2)2-oligodimethylsiloxanem-
(OCH2CH2)8-OCH3; m = 0, 4, and 13] [220]. The siloxane tether distinguishes the PEO-
silane amphiphiles from the analogous conventional PEO-silanes noted above which 
contain a short alkane (e.g. propyl) spacer [147, 201, 202, 246]. The siloxane tether is 
characterized by high flexibility resulting from the wide bond angle (~145°) and low 
barrier to linearization (~0.3 kcal mol-1) of Si-O-Si dimethylsiloxane bonds, features that 
give rise to low glass transition temperatures (e.g. PDMS, Tg = -125 °C) [244, 245]. Like 
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 a silicone elastomer, the siloxane tether is also hydrophobic, imparting an amphiphilic 
character to these PEO-silanes. We anticipated that the flexibility and similarly 
hydrophobic nature of the siloxane tether would facilitate water-driven migration to the 
surface of a bulk-modified silicone thereby reducing protein adsorption. Indeed, when 
the PEO-silane amphiphiles (m = 0, 4, and 13) were bulk-crosslinked with α,ω-bis(Si-
OH) PDMS (Mn = 3000 g mol-1), protein resistance [220], as well as bacteria and diatom 
resistance [247], increased with siloxane tether length. Furthermore, extensive atomic 
force microscopy (AFM) analysis has confirmed the water-driven migration of PEO to 
these silicone coating surfaces to form nanocomplex surfaces [222]. Herein, we 
evaluated the impact of PEO segment length by bulk crosslinking a medical grade RTV 
silicone with three PEO-silane amphiphiles of different PEO segment lengths (n = 3, 8, 
and 16) and a single siloxane tether length (m = 13) (Figure 2.1). 
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Figure 2.1. Structures of PEO-silane amphiphiles, PEO-controls, and siloxane-
control. 
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 Given the protein resistance of PEO oligomers when surface-grafted onto a 
model substrate [142], the PEO-silane amphiphile (n = 8) was selected for our previous 
work to enhance the protein resistance of bulk-modified silicones [220-222, 247-249]. 
Thus, for this study, values of “n” (3, 8, and 16) were chosen as they are “substantially” 
different from one another (by a factor of approximately two) and thus were predicted to 
have different restructuring potentials. Analogous conventional PEO-silanes or “PEO-
controls” (i.e. no siloxane tether, n = 3, 8, and 16) as well as a “siloxane-control” (i.e. no 
PEO segment, m = 13) were likewise evaluated to highlight the effect of the siloxane 
tether. Water-driven surface restructuring was quantified by temporal static contact angle 
analysis of water droplets, and resistance to fibrinogen was also measured. In addition, 
PEO-silane amphiphiles, PEO-controls and the siloxane-control were each surface-
grafted onto silicon wafers in order to evaluate their protein resistance in the absence of 
surface restructuring. This study therefore represents an effort to better understand the 
influence of the siloxane tether and PEO segment length on the protein resistance and 
surface restructuring of PEO-silanes through systematic comparisons versus controls. 
 
2.3 Materials and Methods 
2.3.1 Materials 
Vinyltriethoxysilane (VTEOS), triethoxysilane, α,ω-bis-(SiH)oligodimethyl-
siloxane [Mn = 1000–1100 g mol-1 per manufacturer's specifications; Mn = 1096 g mol-1 
per 1H NMR end group analysis; 1H NMR (δ, ppm): 0.05–0.10 (m, 78H, SiCH3), 0.19 
(d, J = 2.7 Hz, 12H, OSi[CH3]2H) and 4.67–4.73 (m, 2H, SiH)] and allyl methyl PEO3 
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 [Mn = 204 g mol-1 per manufacturer's specifications; Mn = 204 g mol-1 per 1H NMR end 
group analysis; 1H NMR (δ, ppm): 3.35 (s, 3H, OCH3), 3.50–3.67 (m, 12H, OCH2CH2), 
4.00 (dt, J = 6.0 and 1.5 Hz, 2H, CH2=CHCH2O), 5.13–5.28 (m, 2H, CH2=CHCH2O) 
and 5.82–5.96 (m, 1H, CH2=CHCH2O)] were purchased from Gelest. Allyl methyl PEO 
[Polyglykol AM 450, Mn = 292–644 g mol-1 per manufacturer's specifications; Mn = 424 
g mol-1 per 1H NMR end group analysis; 1H NMR (δ, ppm): 3.35 (s, 3H, OCH3), 3.51–
3.66 (m, 32H, OCH2CH2), 4.00 (d, J = 5.4 Hz, 2H, CH2=CHCH2O), 5.13–5.28 (m, 2H, 
CH2=CHCH2O) and 5.82–5.96 (m, 1H, CH2=CHCH2O)] was graciously provided by 
Clariant. Anhydrous magnesium sulfate (MgSO4), hydrogen peroxide (H2O2) solution 
(30%), glass microscope slides (75 mm x 25 mm x 1 mm), and phosphate buffer solution 
(PBS, without calcium and magnesium, pH = 7.4) were purchased from Fisher. Sulfuric 
acid (H2SO4, 95–98%), PEO methyl ether [Mn = 750 g mol-1 per manufacturer's 
specifications, Mn = 736 g mol-1 per 1H NMR end group analysis; 1H NMR (δ, ppm): 
3.37 (s, 3H, OCH3) and 3.53–3.73 (m, 64H, OCH2CH2)], sodium hydride (NaH; 60 wt% 
dispersion in mineral oil), allyl bromide, RhCl(Ph3P)3 (Wilkinson's catalyst), Pt-divinyl-
tetramethyl-disiloxane complex (Karstedt's catalyst), and human fibrinogen (HF; Mw = 
340 kDa; lyophilized powder; ≥90% clottable protein) were purchased from Sigma-
Aldrich and were used as received. Organic solvents were also purchased from Sigma-
Aldrich and were dried over 4 Å molecular sieves prior to use. Silicon wafers (111) were 
obtained from University Wafer, Inc. Silica-coated QCM-D sensor crystals (QSX-303) 
were purchased from Q-Sense. Medical-grade RTV silicone (MED-1137) was purchased 
from NuSil. Per manufacturer specifications, MED-1137 is comprised of α,ω-bis(Si-
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 OH)PDMS, silica (11–21%), methyltriacetoxysilane (<5%), ethyltriacetoxysilane (<5%), 
and trace amounts of acetic acid. The Alexa Fluor 546-dye conjugate of HF (AF-546 
HF; Mw = 340 kDa; lyophilized) was obtained from Invitrogen. 
 
2.3.2 Synthetic Approach 
All reactions were run under a N2 atmosphere with a Teflon-covered stir bar to 
agitate the reaction mixture. Chemical structures were confirmed with nuclear magnetic 
resonance (NMR) spectroscopy using a Mercury 300 MHz spectrometer operating in the 
Fourier transform mode and with CDCl3 as the standard. 
 
2.3.2.1 Synthesis of Allyl Methyl PEO16 
Allyl methyl PEO16 was prepared using a procedure adapted from literature [250, 
251]. PEO methyl ether (Mn = 736 g mol-1, 13.98 g, 19 mmol) was dissolved in 90 mL 
tetrahydrofuran (THF) and added dropwise to a chilled (0 °C) NaH dispersion (6.24 g, 
156 mmol) in 120 mL THF. The reaction was then warmed to room temperature (RT) 
and stirred for 6 h. Next, the PEO solution was chilled, allyl bromide (19.32 g, 160 
mmol) in 120 mL THF was added dropwise, and the mixture was warmed to RT and 
stirred for 16 h. The reaction was then filtered to remove precipitates and volatiles 
removed under reduced pressure. The resulting orange oil was dissolved in 75 mL de-
ionized (DI) water and washed three times with 75 mL toluene. The product was 
extracted three times with 50 mL chloroform. The chloroform solution was then dried 
with anhydrous MgSO4, filtered, and volatiles removed under reduced pressure to yield 
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 the final product (8.32 g, 56% yield) as a white, waxy solid. 1H NMR (δ, ppm): 3.36 (s, 
3H, OCH3), 3.51–3.68 (m, 64H, OCH2CH2), 4.00 (dt, J = 5.7 and 1.5 Hz, 2H, CH2=CH-
CH2O), 5.14–5.28 (m, 2H, CH2=CHCH2O) and 5.83–5.96 (m, 1H, CH2=CHCH2O). 
 
2.3.2.2 Synthesis of PEO-Silane Amphiphiles (n = 3, 8, and 16) 
PEO-silane amphiphiles (Figure 2.1) were prepared as previously reported for n 
= 8 [220]. Wilkinson's-catalyzed regioselective hydrosilylation of VTEOS and α,ω-bis-
(SiH)oligodimethylsiloxane13 produced “1” which was then subjected to Karstedt's-
catalyzed hydrosilylation with the designated allyl methyl PEOn. 
 
PEO-silane amphiphile (n = 3). 1 (22.11 g, 17.2 mmol), allyl methyl PEO3 (3.50 
g, 17.2 mmol) and Karstedt's catalyst were reacted together. In this way, the product 
(25.76 g, 94% yield) was obtained. 1H NMR (δ, ppm): 0.00–0.15 (m, 90H, SiCH3), 
0.48–0.55 (m, 2H, SiCH2CH2CH2), 0.56 (s, 3H, SiCH2CH2), 1.09 (d, J = 7.8 Hz, 1H, 
SiCH2CH2), 1.22 (t, J = 7.1 Hz, 9H, SiOCH2CH3), 1.54–1.66 (m, 2H, SiCH2CH2CH2), 
3.38 (s, 3H, OCH3), 3.41 (t, J = 7.2 Hz, 2H, SiCH2CH2CH2), 3.52–3.69 (m, 12H, 
CH2CH2O) and 3.82 (q, J = 7.0 Hz, 6H, SiOCH2CH3). 
 
PEO-silane amphiphile (n = 8). 1 (20.02 g, 15.57 mmol), allyl methyl PEO8 
(6.60 g, 15.57 mmol) and Karstedt's catalyst were reacted together [220]. In this way, the 
product (22.68 g, 85% yield) was obtained. 1H NMR (δ, ppm): -0.02–0.14 (m, 90H, 
SiCH3), 0.47–0.53 (m, 2H, SiCH2CH2CH2), 0.55 (s, 3H, SiCH2CH2), 1.08 (d, J = 7.5 Hz, 
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 1H, SiCH2CH2), 1.22 (t, J = 7.1 Hz, 9H, SiOCH2CH3), 1.52–1.66 (m, 2H, 
SiCH2CH2CH2), 3.37 (s, 3H, OCH3), 3.40 (t, J = 7.2 Hz, 2H, SiCH2CH2CH2), 3.51–3.68 
(m, 32H, CH2CH2O) and 3.81 (q, J = 7.0 Hz, 6H, SiOCH2CH3). 
 
PEO-silane amphiphile (n = 16). 1 (17.98 g, 13.98 mmol), allyl methyl PEO16 
(10.85 g, 13.98 mmol) and Karstedt's catalyst were reacted together. In this way, the 
product (23.55 g, 82% yield) was obtained. 1H NMR (δ, ppm): -0.01–0.15 (m, 90H, 
SiCH3), 0.47–0.54 (m, 2H, SiCH2CH2CH2), 0.55 (s, 3H, SiCH2CH2), 1.09 (d, J = 7.5 Hz, 
1H, SiCH2CH2), 1.22 (t, J = 6.9 Hz, 9H, SiOCH2CH3), 1.52–1.66 (m, 2H, 
SiCH2CH2CH2), 3.37 (s, 3H, OCH3), 3.41 (t, J = 7.2 Hz, 2H, SiCH2CH2CH2), 3.52–3.72 
(m, 64H, CH2CH2O) and 3.82 (q, J = 6.9 Hz, 6H, SiOCH2CH3). 
 
2.3.2.3 Synthesis of Siloxane- and PEO-Controls (n = 3, 8, and 16) 
PEO-controls (i.e. no siloxane tethers) (Figure 2.1) were prepared as previously 
reported for n = 8 by the Karstedt's-catalyzed hydrosilylation of triethoxysilane and the 
designated allyl methyl PEOn (1.1 : 1.0 molar ratio) [220]. 
 
PEO-control (n = 3). Triethoxysilane (5.43 g, 33.1 mmol), allyl methyl PEO3 
(6.14 g, 30.1 mmol) and Karstedt's catalyst were reacted together. In this way, the 
product (7.53 g, 65% yield) was obtained. 1H NMR (δ, ppm): 0.57–0.65 (m, 2H, 
SiCH2CH2CH2), 1.20 (t, J = 6.9 Hz, 9H, SiOCH2CH3), 1.62–1.74 (m, 2H, 
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 SiCH2CH2CH2), 3.36 (s, 3H, OCH3), 3.41 (t, J = 6.9 Hz, 2H, SiCH2CH2CH2), 3.51–3.68 
(m, 12H, CH2CH2O) and 3.80 (q, J = 7.1 Hz, 6H, SiOCH2CH3). 
 
PEO-control (n = 8). Triethoxysilane (4.24 g, 25.8 mmol), allyl methyl PEO8 
(9.94 g, 23.4 mmol) and Karstedt's catalyst were reacted together [220]. In this way, the 
product (9.32 g, 68% yield) was obtained. 1H NMR (δ, ppm): 0.57–0.64 (m, 2H, 
SiCH2CH2CH2), 1.20 (t, J = 7.1 Hz, 9H, SiOCH2CH3), 1.62–1.74 (m, 2H, 
SiCH2CH2CH2), 3.36 (s, 3H, OCH3), 3.41 (t, J = 6.8 Hz, 2H, SiCH2CH2CH2), 3.50–3.66 
(m, 32H, CH2CH2O) and 3.79 (q, J = 7.0 Hz, 6H, SiOCH2CH3). 
 
PEO-control (n = 16). Triethoxysilane (1.57 g, 9.57 mmol), allyl methyl PEO16 
(6.74 g, 8.69 mmol) and Karstedt's catalyst were reacted together. In this way, the 
product (4.17 g, 50% yield) was obtained. 1H NMR (δ, ppm): 0.57–0.65 (m, 2H, 
SiCH2CH2CH2), 1.20 (t, J = 6.9 Hz, 9H, SiOCH2CH3), 1.62–1.74 (m, 2H, 
SiCH2CH2CH2), 3.36 (s, 3H, OCH3), 3.41 (t, J = 6.9 Hz, 2H, SiCH2CH2CH2), 3.50–3.71 
(m, 64H, CH2CH2O) and 3.80 (q, J = 7.0 Hz, 6H, SiOCH2CH3). 
 
Siloxane-control (1). 1 served as the siloxane-control and was prepared as noted 
above for the first step of the synthesis of the PEO-silane amphiphiles. VTEOS (3.53 g, 
18.6 mmol) and α,ω-bis-(SiH)oligodimethylsiloxane (20.37 g, 18.6 mmol) were reacted 
together [220]. In this way, the product (23.65 g, 99% yield) was obtained. 1H NMR (δ, 
ppm): 0.003–0.177 (m, 84H, SiCH3), 0.19 (d, J = 2.7 Hz, 6H, OSi[CH3]2H), 0.56 (s, 3H, 
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 SiCH2CH2), 1.09 (d, J = 7.5 Hz, 1H, SiCH2CH2), 1.23 (t, J = 7.1 Hz, 9H, SiOCH2CH3), 
3.83 (q, J = 7.0 Hz, 6H, SiOCH2CH3) and 4.67–4.73 (m, 1H, SiH). 
 
2.3.3 Coating Preparation 
2.3.3.1 Preparation of Surface-Grafted Coatings on Silicon Wafers 
Silicon wafers (1” x 1”) were cleaned by sequentially sonicating in (10 min) and 
rinsing with acetone, repeating with DI water, and then drying in a 120 °C oven 
overnight. Next, the surfaces of the wafers were oxidized by submerging in a 7 : 3 v/v 
concentrated H2SO4/30% H2O2 (Piranha) solution for 30 min (warning: Piranha solution 
must be handled with extreme caution), removed, rinsed thoroughly with DI water and 
dried under a stream of air. In a typical procedure, grafting solutions comprised of each 
of the PEO-silane amphiphiles, PEO-controls and the siloxane-control were prepared at 
a concentration of 0.012 M in isopropanol (IPA) (30 mL). Following the addition of 1 
drop of DI water, the grafting solutions were mixed in sealed jars for 1 h on a shaker 
table. Next, an oxidized wafer was placed into a jar and remained on a shaker table for 
12 h. Afterwards, the wafers were removed, air dried, and cured under vacuum (36 mm 
Hg) at 150 °C for 12 h. To remove unbound chains, the wafers were sequentially soaked 
(1 h), sonicated (3 min) and rinsed with ethanol, the sequence repeated with DI water 
and then lastly dried under a stream of air. 
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 2.3.3.2 Preparation of Modified Silicone Coatings 
Glass microscope slides were sequentially rinsed with dichloromethane (DCM) 
and acetone followed by drying in a 120 °C oven overnight. Casting solutions were 
prepared by combining 2.0 g MED-1137 silicone in 6 g (9 mL) hexane and mixing with 
a vortexer until a homogenous solution was obtained. The PEO-silane amphiphiles, 
PEO-controls and siloxane-control were each added to individual casting solutions at 50 
µmol of silane per 1.0 g silicone and mixed thoroughly. Solutions were solvent-cast onto 
leveled glass microscope slides (1.5 mL per slide) and a polystyrene Petri dish cover 
placed on top of each so as to slow solvent evaporation and prevent bubble formation. 
The films were allowed to cure for one week at RT and immediately used for designated 
analyses. 
 
2.3.4 Surface Characterization 
2.3.4.1 X-Ray Photoelectron Spectroscopy (XPS) 
Surface composition analysis of surface-grafted coatings on silicon wafers was 
performed with a KRATO AXIS Ultra Imaging X-ray Photoelectron Spectrometer with 
a monochromatized Mg Kα source and operating at a base pressure of ~2% x 10-9 mbar. 
The area of analysis was 7 x 3 mm. Elemental atomic percent compositions were 
determined from three survey spectra sweeps performed from 0 to 1100 eV. High 
resolution (HR) analyses with a pass energy of 40 eV were performed with a take-off 
angle of 90°. HR scans (180 s sweeps) were performed at 526 to 536 eV for O 1s, 280 to 
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 295 eV for C 1s, and 96 to 106 eV for Si 2p. Raw data was quantified and analyzed 
using XPS Peak Processing software. 
 
2.3.4.2 Ellipsometry 
The thickness of surface-grafted coatings on silicon wafers was measured via 
ellipsometry (Alpha-SE, J.A. Woollam) with an incident angle of 70° in the spectral 
range of 380–900 nm and in the high-precision mode (30 s data acquisition time). The 
average thickness of the oxide layer of an oxidized silicon wafer was determined at three 
regions of a wafer specimen (taken from a wafer designated for grafting with a particular 
composition) using a standard two-layer (silica-silicon) optical model included in the 
manufacturer's software. To measure the thickness of the grafted chains, the previously 
determined oxide layer thickness was utilized in a second optical model that included the 
third “Cauchy layer” (polymer-silica-silicon). The index of refraction (n) was set to 
1.450 which is that of crystalline PEO [248, 252]. The average thickness (h) of the 
grafted layers was based on four individual wafers, each measured at three different 
regions. 
 
2.3.4.3 Water Contact Angle Analysis 
Static contact angles (θstatic) of DI water droplets were measured at RT using a 
CAM-200 goniometer (KSV Instruments) equipped with an autodispenser, video 
camera, and drop-shape analysis software (Attension Theta). Following deposition, a 5 
µL sessile drop of water was iteratively measured over a 2 min (surface-grafted wafers) 
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 and 3 min (silicone-based coatings) period. The reported θstatic values of the surface-
grafted wafers were based on four individual wafers, each measured at three different 
areas (12 measurements total). The θstatic for the silicone-based coatings was an average 
of three measurements from different areas of the same film surface. 
 
2.3.4.4 Protein Adsorption 
Protein adsorption onto surface-grafted coatings was measured by QCM-D (Q-
Sense E4). Silicon dioxide coated sensors (50 nm thickness; Q-Sense) were 
ultrasonically cleaned with acetone and DI water as described above for silicon wafers. 
Following exposure to oxygen plasma for 2 min (Harrick Plasma, PDC-001), the sensors 
were surface-grafted with the designated PEO-silane amphiphile, PEO-control or 
siloxane-control as described above for silicon wafers. Contact angle analysis was used 
to verify grafting. Grafted sensors were subjected to the following sequence: (1) 150 µL 
min-1 flow of PBS until the frequency and dissipation values remained constant for >5 
min, (2) 150 µL min-1 flow of 100 µg mL-1 HF in PBS for 20 min and (3) 150 µL min-1 
flow of PBS for 5 min to remove loosely bound protein. The manufacturer's software 
was used to process the raw data and determine the mass of HF adsorbed to each sensor. 
The adsorption of AF-546 HF onto silicone coatings was measured via 
fluorescence microscopy. A silicone isolator well (20 mm well diameter, 2 mm depth; 
McMaster-Carr) was pressed against silicone films thereby creating a seal which 
prevented leakage of solution from the well. Fibrinogen solution (100 µg mL-1 in PBS, 
0.7 mL) was added to each well. (Note: per manufacturer specifications, the AF-546 was 
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 first dissolved in 0.1 M NaHCO3 to obtain a 1.5 mg mL-1 solution and was further 
diluted in PBS to obtain a final concentration of 0.1 µg mL-1) After 3 h at RT (protected 
from light), the solution was removed and 0.7 mL of fresh PBS was then added to each 
well and removed after 5 min. This process was repeated five times with fresh PBS and 
lastly one time with DI water. The samples were dried under a stream of air and 
protected from light until imaged. For each coating, an additional specimen was 
prepared and likewise rinsed with PBS and DI water, but without exposure to AF-546 
(i.e. soaked 3 h in PBS) in order to correct for the background intensity. 
A FV1000 (Olympus) laser scanning confocal microscope was used for 
quantification of protein adsorption onto all films. Imaging conditions, both in excitation 
and collection, were identical for all samples: objective (SPLSAPO 10x objective, NA 
0.40), laser excitation type and intensity (HeNe 543 nm source), field of view and 
resolution (256 x 256 pixels, 317 x 317 micron field of view), depth (40 slices at 1 mm 
per slice), slice averaging, and collection (150 mm pinhole, 560 nm long-pass filter 
followed by a 560–660 nm band-pass filter, identical photomultiplier voltages/ 
sensitivities). Data analysis was performed on the FV10-ASW v3.1 software suite 
(Olympus). Each surface was imaged in three locations and aggregate intensities 
computed. These were compared to three images obtained from the analogous surface 
that had similar treatment without protein exposure. Changes in intensity from exposure 
to protein were then obtained and compared, with errors reported as the standard 
deviation of three measurements. 
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 2.4 Results and Discussion 
2.4.1 Surface-Grafted Coatings on Silicon Wafers 
The protein resistance of PEO-silane amphiphiles (n = 3, 8, and 16) in the 
absence of water-driven restructuring to the surface was evaluated with surface-grafted 
coatings prepared on silicon wafers. PEO-controls (n = 3, 8, and 16) and the siloxane-
control were likewise evaluated to elucidate the impact of the siloxane tether. 
 
2.4.1.1 X-Ray Photoelectron Spectroscopy (XPS) 
The surface-grafting of conventional PEO-silanes onto silicon wafers has been 
widely reported [151-153]. Likewise, the successful surface-grafting of PEO-silane 
amphiphiles (n = 3, 8, and 16) was confirmed via XPS with the PEO-control (n = 8) and 
siloxane-control serving as controls. Surface elemental atomic percent compositions are 
reported in Table 2.1. For the oxidized silicon wafer, the O 1s and Si 2p peaks 
correspond to the wafer composition whereas the carbon (C 1s) is attributed to adsorbed 
contaminants [253, 254]. Following surface-grafting, a decrease in Si 2p and increase in 
C 1s content was observed as expected. 
 
Table 2.1. Surface atomic % compositions by XPS. 
C 1s C-Si/C-C C-O O 1s Si 2p
Surface Total 284.5 eV 286.4 eV
Oxidized silica 5 34 61
Siloxane-control 34 94 6 29 38
n = 3 24 82 18 29 47
n = 8 22 71 29 34 44
n = 16 26 48 52 33 42
PEO-control 
(n = 8) 26 38 62 35 38  
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 To further confirm surface-grafting, the C 1s peak was deconvoluted into two 
peaks of different binding energies and normalized to the peak centered at 284.5 eV 
(Figure 2.2). These peaks correspond to the C-C/C-Si (at 284.5 eV) and C-O (at 286.4 
eV) of PEO [147]. The areas of the C-C/C-Si and C-O peaks are reported in Table 2.1. 
When surfaces were grafted with PEO–silane amphiphiles, C-O content increased with 
PEO segment length (n) and a concomitant decrease in C-C/C-Si content was also 
observed. As expected, the relative quantity of C-O on the surface grafted with the PEO-
control was greatest due to the absence of C-Si associated with the siloxane tether that 
was present on all other samples. Finally, for the surface-grafted siloxane-control, C-O 
content was very low and may be attributed to residual unreacted ethoxy groups. 
Together, these results confirm the successful grafting of PEO-silane amphiphiles to 
silicon wafers. 
 
280282284286288290292
Binding Energy (eV)
PEO-control (n = 8)
Siloxane-control
n = 3
n = 8
n = 16
 
Figure 2.2. HR C 1s XPS spectra of silicon wafers grafted with PEO-silane 
amphiphiles (n = 3, 8, and 16) as well as the PEO-control (n = 8) and siloxane-
control. 
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 2.4.1.2 Ellipsometry 
As chain spacing is known to influence the protein resistance of grafted PEO 
coatings [144, 252], it was important to ensure that the graft density was similar for all 
samples using ellipsometry. Dry thickness values (h) of grafted PEO-silane amphiphiles, 
PEO-controls, and siloxane-control were measured and the obtained values of h were 
then used to estimate the chain density (σ) (Table 2.2) [194, 255, 256]: 
 
σ = (h ρ NA) / Mn     (Equation 2.1) 
 
where ρ is the density of the dry grafted layer, NA is Avogadro's number and Mn is the 
number average molecular weight of the chain. The chain distance or “spacing” (D, nm) 
(i.e. distance between grafting sites) was also calculated (Table 2.2) [256]: 
D = (4 / π σ)1/2     (Equation 2.2) 
 
Utilizing the described grafting conditions, all grafted layers were found to have 
similar chain spacing (D) (1.0–1.5 nm) except for the PEO-control (n = 8). Initially, this 
particular composition yielded high values of h (~4.3 nm) which are significantly higher 
than the fully extended chain length of the PEO segment (~2.8 nm) [257], indicative of 
substantial multilayer formation. To prevent multilayer formation and increase D, the 
grafting conditions for the PEO-control (n = 8) were adjusted as follows: grafting 
solution concentration = 0.006 M, exclusion of water droplet from grafting solution, and 
cure under vacuum at RT. 
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 Table 2.2. Ellipsometry data for grafted surfaces. 
Surface
Mn
(g/mol)
Density ρ
(g/mL)
Measured
Thickness h
(nm)
Chain Density
σ = (hρ/Mn) x NA
(chains/nm2)
Chain Spacing
D = (4/πσ)1/2 
(nm)
PEO Flory
Spacing
2Rf = 2aN3/5 
(nm)
Siloxane Flory 
Spacing
2Rf = 2aN1/3 
(nm)
Siloxane-control 1286 1.01 2.5 ± 0.9 1.2 ± 0.4 1.1 ± 0.2 n/a 2.4
PEO-control (n = 3) 368 1.04 0.6 ± 0.1 1.0 ± 0.2 1.1 ± 0.1 1.4 n/a
PEO-control (n = 8) 588 1.13 2.3 ± 0.2 2.6 ± 0.2 0.70 ± 0.03 2.4 n/a
PEO-control (n = 16) 940 1.16 1.2 ± 0.2 0.9 ± 0.2 1.2 ± 0.1 3.7 n/a
Amphiphile (n = 3) 1490 1.04 2.1 ± 0.2 0.9 ± 0.1 1.2 ± 0.1 1.4 2.4
Amphiphile (n = 8) 1710 1.13 1.7 ± 0.2 0.6 ± 0.1 1.4 ± 0.1 2.4 2.4
Amphiphile (n = 16) 2062 1.04 3.1 ± 0.8 0.9 ± 0.2 1.2 ± 0.1 3.7 2.4  
 
For all compositions of surface-grafted chains to be in the brush regime, D must 
be less than twice the Flory radius (2Rf) [252]. For each chain composition, Rf was 
calculated on the basis of the length of one monomer (a) and the degree of 
polymerization (N) as follows [252, 258, 259]: (i) for the siloxane-control in a poor 
solvent (water): Rf = aN1/3, where a = 0.5 nm and N = 13 and (ii) for the PEO-controls in 
a good solvent (water): Rf = aN3/5, where a = 0.35 nm and N = n. For all of these 
controls, D < 2Rf. Calculation of Rf for the PEO-silane amphiphiles is complicated by 
the fact that these contain two “blocks” (i.e. siloxane tether and PEO segment) of 
differing solubility in water. Thus, Rf was individually calculated on the basis of both the 
siloxane tether and the PEO segment [248] using the aforementioned equations. For all 
grafted PEO-silane amphiphiles, D < 2Rf, even when considering the lower of the two 
calculated Rf values. Thus, for all grafted chains, a brush regime was obtained. 
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 2.4.1.3 Water Contact Angle Analysis 
An oxidized silicon wafer provides a physically stable surface such that the 
concentration of grafted chains is maintained at the surface, irrespective of an air or 
water environment. Thus, the impact of PEO-silane amphiphile structure, including PEO 
segment length, on surface wettability (i.e. θstatic) may be elucidated by comparing these 
grafted surfaces to those prepared with the PEO-controls and the siloxane-control. θstatic 
was measured immediately after water droplet deposition (0 s) and at 2 min (Figure 
2.3). For all grafted surfaces, θstatic (0 s) was very similar to θstatic (2 min) due to the 
expected lack of surface restructuring. For the siloxane-control grafted surface, the 
hydrophobicity of the siloxane tether (and the absence of a hydrophilic PEO segment) 
led to a hydrophobic surface as characterized by θstatic > 90° [260]. In the case of PEO-
control grafted surfaces, surface hydrophilicity increased (i.e. θstatic decreased) with 
increased PEO segment length (n). This trend was likewise observed for PEO-silane 
amphiphile grafted surfaces. However, due to the contributions of the PEO–silane 
amphiphiles' hydrophobic siloxane tethers, these surfaces were substantially more 
hydrophobic versus the corresponding PEO-controls (i.e. same n). 
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Figure 2.3. Static contact angle (θstatic) of surface-grafted silicon wafers at 0 s (dark) 
and 2 min (light) following placement of water droplet. Each bar represents the 
average and standard deviation of measurements performed in triplicate on four 
identically prepared samples. 
 
2.4.1.4 Protein Adsorption 
Human fibrinogen (HF) was chosen as the protein for these adsorption studies 
due to its well-established influence in surface-induced thrombosis by causing platelet 
adhesion and activation [14-19]. Its use in evaluating the thromboresistance of materials 
in vitro has also been well established [16, 136, 142, 169, 189, 194, 201, 221, 247-249, 
252, 261, 262]. Adsorption of HF onto surface-grafted silicon wafers was measured by 
quartz crystal microbalance with dissipation monitoring (QCM-D) (Figure 2.4). QCM-D 
has been widely used for measuring adsorption of proteins on low-fouling grafted 
monolayers and thin films [262-265]. The Sauerbrey model was used to approximate the 
mass of fibrinogen due to the relatively low dissipation of the adsorbed protein [261]. 
Furthermore, the changes in frequency and dissipation for the most protein-resistant 
surfaces were too small for the software to accurately calculate the mass using a 
viscoelastic (Voigt) model. Mass was calculated from the seventh overtone of frequency. 
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Figure 2.4. QCM-D-measured adsorption of human fibrinogen (HF) onto silica-
coated sensors grafted with the siloxane-control [blue solid line], PEO-silane 
amphiphiles (n = 3, 8, and 16) [dashed lines] and PEO-controls (n = 3, 8, and 16) 
[solid lines]. After equilibration for 5 min with PBS, the sensors were exposed to 
HF for 20 min and then to PBS for 5 min. 
 
Proteins, including HF, are known to adsorb more onto hydrophobic versus 
hydrophilic surfaces [22, 125]. Indeed, the degree of hydrophobicity of the grafted 
surfaces (as indicated by θstatic reported in Figure 2.3) correlates well with the observed 
amounts of HF adsorbed (Figure 2.4). For instance, the siloxane-control produced the 
most hydrophobic grafted surface which led to the highest level of HF adsorption. Due 
to increasing hydrophilicity, the protein resistance of grafted surfaces with PEO-silane 
amphiphiles as well as PEO-controls increased with PEO segment length (n). Notably, 
for a given PEO segment length (n), the PEO-silane amphiphile adsorbed more HF than 
the PEO-control which is consistent with the higher hydrophobicity of the former. These 
results agree with the exceptionally low fouling nature observed for PEO chains grafted 
onto stable surfaces [140, 142, 145, 146, 151, 153]. 
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 2.4.2 Bulk-Modified Silicone Coatings 
In order to evaluate the capacity of the silanes to undergo water-driven surface 
reorganization and reduce protein adsorption, a medical-grade RTV silicone was bulk-
modified with PEO-silane amphiphiles (n = 3, 8, and 16), PEO-controls (n = 3, 8, and 
16) and the siloxane-control. Each silane was introduced at a constant level (50 µmol of 
silane per 1.0 g silicone) and the solvent-cast films were cured on glass slides (Figure 
2.5). The thicknesses of all films were measured by an electronic caliper and found to be 
0.14 ± 0.01 mm. When modified with the hydrophobic siloxane-control, the coating 
appearance resembled that of the unmodified silicone. The lack of increased opacity of 
these films was attributed to the solubility of the siloxane-control in the silicone matrix. 
In contrast, silicones modified with PEO-controls were substantially more opaque and 
notably so when compared to those prepared with the corresponding PEO-silane 
amphiphiles. Opacity increased, particularly for the PEO-controls, as the PEO segment 
length (n) increased. The lesser increase in opacity of silicones modified with PEO-
silane amphiphiles may be attributed to reduced phase separation stemming from the 
solubility of the hydrophobic siloxane tether in the silicone matrix. 
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Figure 2.5. Unmodified silicone and silicones bulk-modified with PEO-silane 
amphiphiles (n = 3, 8, and 16), PEO-controls (n = 3, 8, and 16), and the siloxane-
control. 
 
2.4.2.1 Water Contact Angle Analysis 
As noted, AFM was previously used to confirm the water-driven formation of a 
PEO-enriched surface for silicone modified with the PEO-silane amphiphile (n = 8) 
[222]. Water-driven surface restructuring of bulk-modified silicones was evaluated by 
temporally measuring θstatic of a water droplet placed on the surface over a 3 min period 
(Figure 2.6). 
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Figure 2.6. Static water contact angles measured over three minutes on bulk-
modified silicone films. Bars are organized as the time after initial drop placement 
from dark color to light as follows: 0 s, 15 s, 30 s, 1 min, 2 min and 3 min. Each bar 
represents the average of three contact angles measured at the same time point on 
the same sample and the error bar is the standard deviation. 
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 As expected, the unmodified silicone was very hydrophobic and the θstatic value 
did not change significantly during the 3 min measurement. The siloxane-control 
produced a modified silicone that was also very hydrophobic but displayed a slight 
decrease in θstatic over 3 min (Δ = ~12°). However, at 3 min, θstatic was still >90° and 
therefore hydrophobic [260]. Notably, silicones modified with PEO-controls also 
remained hydrophobic after 3 min (θstatic,3min > 90°), similarly exhibiting only a moderate 
decrease in θstatic 3 min after droplet deposition (n = 3, Δ = ~19°; n = 8, Δ = ~15°; n = 16, 
Δ = ~12°). Thus, the PEO-controls demonstrated a limited capacity to migrate to the 
surface-water interface and hydrophobicity was only slightly diminished with decreased 
PEO length. In contrast, when modified with PEO-silane amphiphiles, silicone surfaces 
underwent extensive and rapid water-driven surface reorganization as noted by large 
decreases in θstatic over a 3 min period (n = 3, Δ = ~33°; n = 8, Δ = ~88°; n = 16, Δ = 
~59°). Thus, the siloxane tether critically facilitates the migration of PEO segments to 
the surface-water interface. Due to this enhanced surface reorganization, initially 
hydrophobic surfaces quickly became more hydrophilic, with hydrophilicity increasing 
in the order: n = 3 (θstatic,3min = ~84°) < n = 16 (θstatic,3min = ~57°) < n = 8 (θstatic,3min = 
~29°). Thus, the PEO segment length of PEO–silane amphiphiles produced an obvious 
impact. For n = 8, modified silicones displayed the greatest decrease in θstatic over 3 min 
(i.e. Δ) and also achieved the highest hydrophilicity (i.e. θstatic,3min). For n = 16, the longer 
PEO segment length likely imparts a greater steric challenge for water-driven surface 
reorganization. In contrast, for n = 3, while short PEO segments may more readily move 
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 to the surface-water interface, the reduced number of PEO repeating units diminishes the 
relative potential to increase hydrophilicity. 
 
2.4.2.2 Protein Adsorption 
Protein resistance of the bulk-modified silicone “thick” films was determined via 
confocal microscopy [220-222, 249]. Adsorption of fluorescently-labeled HF (100 µg 
mL-1) was measured on silicone in terms of absolute fluorescence intensity and that 
normalized to unmodified silicone (Figure 2.7). 
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Figure 2.7. Fibrinogen adsorption on bulk-modified silicones as measured by 
fluorescence intensity with confocal microscopy. Each bar represents the average 
and standard deviation of pixel intensity for three images normalized to unmodified 
silicone. Statistical significance was determined for low-fouling samples by one-way 
analysis of variance (Holm-Sidak method where * indicates p < 0.05). 
 
The unmodified silicone, due to its high hydrophobicity, resulted in 
characteristically high protein adsorption. Due to its hydrophobic nature, the siloxane-
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 tether produced modified silicones with similarly high protein adsorption. Despite 
modification of silicones with PEO-controls (n = 3, 8, and 16), protein adsorption was 
also high. This is notably contrary to the high protein repellency of PEO-controls when 
grafted onto silicon wafers (Figure 2.4). This can be explained by the contact angle 
analysis that demonstrates that the PEO segments comprising the PEO-controls are 
severely inhibited in their migration to the surface-water interface where protein 
adsorption occurs (Figure 2.6). The PEO-silane amphiphile (n = 3), due to its short PEO 
segment length and corresponding inability to effectively hydrophilize the surface-water 
interface (Figure 2.6), also produced modified silicones that adsorbed high levels of 
protein. However, distinctively low protein adsorption was observed for silicones 
modified with PEO–silane amphiphiles (n = 8 and 16), with the PEO–silane amphiphile 
(n = 8) yielding the lowest of the two. This agrees with the contact angle analysis that 
shows the rapid transition from a hydrophobic to hydrophilic surface, indicative of 
highly efficient water-driven PEO surface migration (Figure 2.6). Thus, while these 
PEO-silane amphiphiles demonstrated reduced protein repellency versus the 
corresponding PEO-controls when surface-grafted onto silicon wafers (Figure 2.4), they 
are superior and highly effective in reducing protein adsorption onto bulk-modified 
silicones. 
 
2.5 Conclusions 
While the exceptional protein resistance of PEO (e.g. conventional PEO-silanes) 
is well described, these observations have largely been made when PEO is grafted to a 
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 physically stable substrate (e.g. silicon wafer). In this way, migration of the PEO to the 
surface-water interface (where protein and other biological adhesion occurs) is not 
required. However, when PEO is used to bulk-modify a silicone elastomer, rapid water-
driven restructuring is essential in order to affect protein resistance. In this work, both 
surface-grafted silicon and bulk-modified silicones were prepared with PEO-silane 
amphiphiles comprised of a siloxane tether (m = 13) and a PEO segment of variable 
lengths (n = 3, 8, and 16) as well as the corresponding PEO-controls (i.e. no siloxane 
tether). Surface-grafted PEO-controls, due to their greater hydrophilicity, demonstrated 
superior resistance to fibrinogen versus the PEO-silane amphiphiles. However, when 
used to bulk-modify a silicone, PEO-controls produced surfaces that remained 
hydrophobic after 3 min of exposure to water. As a result, these surfaces exhibited poor 
resistance to protein adsorption. In contrast, PEO-silane amphiphiles (n = 8 and 16) 
demonstrated dramatic and rapid water-driven surface restructuring, becoming extremely 
hydrophilic after exposure to water for only 3 min. As a result, these surfaces displayed 
exceptionally high resistance to fibrinogen. While the PEO-silane amphiphile (n = 3) 
also exhibited water-driven restructuring, the achieved hydrophilicity and resistance to 
protein was diminished by its low PEO content. The enhanced potential of PEO-silane 
amphiphiles to migrate to the surface-water interface and reduce protein adsorption may 
be attributed to the hydrophobic nature as well as flexibility of the siloxane tether which 
allows movement of the tether and attached PEO segment through the silicone network. 
Furthermore, these results point to the limitations of predicting PEO's protein resistance 
using model substrates. 
55 
 
CHAPTER III  
PROTEIN RESISTANCE EFFICACY OF PEO-SILANE AMPHIPHILES: 
DEPENDENCE ON PEO-SEGMENT LENGTH AND CONCENTRATION IN 
SILICONE 
3.1 Overview 
In contrast to modification with conventional PEO-silanes (i.e. no siloxane 
tether), silicones with dramatically enhanced protein resistance have been previously 
achieved via bulk-modification with poly(ethylene oxide) (PEO)-silane amphiphiles α-
(EtO)3Si(CH2)2-oligodimethylsiloxane13-block-PEOn-OCH3 when n = 8 and 16 but not 
when n = 3. In this work, their efficacy was evaluated in terms of optimal PEO-segment 
length and minimum concentration required in silicone. For each PEO-silane amphiphile 
(n = 3, 8, and 16), five concentrations (5, 10, 25, 50, and 100 µmol per 1 g silicone) were 
evaluated. Efficacy was quantified in terms of the modified silicones’ abilities to 
undergo rapid, water-driven surface restructuring to form hydrophilic surfaces as well as 
resistance to fibrinogen adsorption. Only n = 8 and 16 were effective, with a lower 
minimum concentration in silicone required for n = 8 (10 µmol per 1 g silicone) versus n 
= 16 (25 µmol per 1 g silicone). 
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 3.2 Introduction 
Silicone is a widely used material for blood-contacting medical devices such as 
hemodialysis catheters, catheter balloons, and cardiac pacing leads [224-226]. Silicone 
materials strike an excellent balance of durability, flexibility, and processability that 
makes them well-suited for such applications. Unfortunately, due to their hydrophobic 
nature, silicones suffer from poor resistance to protein adsorption which causes 
subsequent thrombus formation [228, 229]. This surface-induced thrombosis may lead to 
a variety of device complications including obstruction of blood flow [76], 
thromboemboli [49, 69, 79, 80], and infection [26-29], all of which result in diminished 
device efficacy or failure, ultimately jeopardizing patient health. Antithrombotic drugs 
can reduce such complications [30-36] but put the patient at risk for major bleeding 
events [37-41]. Therefore, silicone materials that are inherently resistant to protein 
adsorption and thrombosis, thereby reducing the need for antithrombotic drugs, would 
dramatically improve the efficacy and safety of blood-contacting medical devices. 
Perhaps the most popular strategy to achieve protein resistance is the introduction 
of poly(ethylene oxide) [PEO or poly(ethylene glycol) (PEG)] to model substrates (e.g. 
gold and silicon) [140-142, 144, 151-153] as well as to various biomaterials [133-136, 
139, 149, 150, 163, 169, 203-209] including silicone [138, 147, 161, 201, 202]. PEO 
inhibits protein adsorption by a number of mechanisms including steric repulsion [155, 
156], blockage of underlying adsorption sites [158], and formation of a repulsive 
“hydration layer” [159]. Furthermore, in addition to its biocompatibility [239], PEO’s 
excellent oxidative stability under biological conditions has been demonstrated [177]. 
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 Despite the promising performance of PEO coatings in vitro, their performance in vivo 
has been disappointing and inconsistent [169-171]. 
In order for PEO to effectively diminish protein adsorption, its surface 
concentration must be sufficiently high [142, 144, 164, 165]. Thus, for the modification 
of silicones, it is critical that a PEO-enriched surface is formed at the aqueous (i.e. 
biological) interface where protein adsorption occurs. Due to the low surface energy 
[242, 243] and high chain flexibility [244, 245] of silicones, surface reorganization 
occurs depending on the environment (e.g. in air or underwater) [240]. For example, 
silicone can be plasma-treated to improve surface hydrophilicity, but unless maintained 
in water, it will undergo hydrophobic recovery [241]. Both bulk- and surface-
modification strategies used to introduce PEO into silicone have been shown to similarly 
undergo hydrophobic recovery. These include silicones bulk-crosslinked with 
conventional PEO-silanes such as triethoxysilylpropyl PEO monomethyl ether 
[(EtO)3Si-(CH2)3-PEOn-OCH3] [201, 202] and allyl PEO monomethyl ether 
[CH2=CHCH2-PEOn-OCH3] [246] as well as silicones surface-grafted with allyl PEO 
monomethyl ether [147, 246]. We recently demonstrated that for silicones bulk-modified 
with PEO-silanes (n = 3, 8, and 16), poor surface restructuring of PEO was observed 
[266]. In this way, the surfaces remained hydrophobic, even after exposure to water, and 
exhibited high protein adsorption similar to that of unmodified silicone. The inability of 
conventional PEO-silanes to undergo water-driven surface restructuring could explain 
the poor protein resistance of other bulk-modified polymers [161, 202, 205]. 
58 
 
 We have reported silicones with enhanced protein resistance prepared via bulk-
modification with PEO-silane amphiphiles bearing an oligodimethylsiloxane (ODMS) 
tether [α-(EtO)3-(CH2)3-ODMSm-block-PEOn-OCH3] [220-222, 266]. Silicones bulk-
modified with these PEO-silane amphiphiles were observed to undergo substantial, 
rapid, water-driven surface restructuring to form a PEO-enriched surface (by atomic 
force microscopy [AFM]) [222] with high resistance to proteins [220-222, 266] and 
other biofoulers [247]. Their ability to function as an effective “surface-modifying 
additive” (SMA) can be attributed to the ODMS tether’s flexibility [244, 245] as well as 
similar composition and thus compatibility with the silicone matrix. The extent of water-
driven surface restructuring and protein resistance has been shown to be dependent on 
ODMS tether length and PEO-segment length. For instance, for PEO-silane amphiphiles 
of constant PEO-segment length (m = 0, 4, and 13; n = 8), protein resistance of bulk-
modified silicones increased with siloxane tether length [220]. More recently, silicones 
were modified using PEO-silane amphiphiles with a variable PEO-segment length (m = 
13; n = 3, 8, and 16) (Figure 3.1) [266]. Water-driven change from a hydrophobic to 
hydrophilic (i.e. PEO-enriched) surface was evaluated by temporally measuring the 
static contact angle (θstatic) of a deposited water droplet. While initially hydrophobic 
(θstatic, 0 s ≈ 115°), a rapid and substantial decrease of θstatic was observed when silicone 
was modified with n = 8 (θstatic, 3 min ≈ 29°) and n = 16 (θstatic, 3 min ≈ 57°), but less so with 
n = 3 (θstatic, 3 min ≈ 84°). Thus, the most hydrophilic PEO-modified silicone surface was 
achieved with n = 8. In contrast, silicone modified with analogous conventional PEO-
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 silanes (n = 3, 8, and 16) remained hydrophobic with minimal decrease in θstatic as a 
result of their limited surface-restructuring potential. 
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Figure 3.1. PEO-silane amphiphile chemical structure (n = 3, 8, and 16) and 
illustration of water-driven surface restructuring of bulk-modified silicone. 
 
In the previous study, PEO-silane amphiphiles (m = 13; n = 3, 8, and 16) were 
incorporated into silicone at a single molar concentration of 50 µmol (per 1 gram of 
silicone). Due to their different respective molecular weights of the PEO segment (i.e. 
the n value), at this single molar concentration, the “wt% of PEO” was variable: n = 3 < 
n = 8 < n = 16 (Table 3.1). In this study, the efficacy of these PEO-silane amphiphiles to 
undergo water-driven restructuring and subsequently reduce protein adsorption was 
similarly evaluated. However, five concentrations (5, 10, 25, 50, and 100 µmol per 1 g 
silicone) were evaluated to determine the minimum concentration necessary. 
Furthermore, this series permitted determination as to whether it was PEO length (n) or 
PEO concentration (irrespective of length) that impacted protein resistance efficacy. 
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 Table 3.1. Total wt% of PEO-silane amphiphile (i.e. surface-modifying additive, 
SMA) and corresponding wt% of PEO in a modified silicone for each total molar 
concentration of SMA. [wt% PEO calculated as the wt% SMA multiplied by the 
ratio of PEO Mn (n x 44 g/mol) to SMA Mn] 
Molar Concentration 
(per 1 g silicone)
n = 3 n = 8 n = 16
wt% SMA wt% PEO wt% SMA wt% PEO wt% SMA wt% PEO
5 µmol 0.74 0.07 0.85 0.17 1.02 0.35
10 µmol 1.47 0.13 1.68 0.35 2.02 0.69
25 µmol 3.59 0.32 4.10 0.84 4.90 1.67
50 µmol 6.93 0.61 7.88 1.62 9.35 3.19
100 µmol 12.97 1.15 14.60 3.01 17.10 5.84  
 
3.3 Materials and Methods 
3.3.1 Materials 
Vinyltriethoxysilane, α,ω-bis-(SiH)oligodimethylsiloxane [Mn = 1000 – 1100 
g/mol per manufacturer’s specifications; Mn = 1096 g/mol per 1H NMR end group 
analysis; 1H NMR (300 MHz, CDCl3, δ): 0.05 – 0.10 (m, 78H, SiCH3), 0.185 (d, J = 2.7 
Hz, 12H, SiCH3), and 4.67 – 4.73 (m, 2H, SiH)], and allyloxy(triethylene oxide) methyl 
ether [Mn = 204 g/mol per manufacturer’s specifications; Mn = 204 g/mol per 1H NMR 
end group analysis; 1H NMR (300 MHz, CDCl3, δ): 3.35 (s, 3H, OCH3), 3.50 – 3.67 (m, 
12H, OCH2CH2), 4.00 (dt, J = 6.0 and 1.5 Hz, 2H, CH2=CHCH2O), 5.13 – 5.28 (m, 2H, 
CH2=CHCH2O), and 5.82 – 5.96 (m, 1H, CH2=CHCH2O)] were purchased from Gelest. 
Allyl methyl PEO [Polyglykol AM 450, Mn = 292 – 644 g/mol per manufacturer’s 
specifications; Mn = 424 g/mol per 1H NMR end group analysis; 1H NMR (300 MHz, 
CDCl3, δ): 3.35 (s, 3H, OCH3), 3.51 – 3.66 (m, 32H, OCH2CH2), 4.00 (d, J = 5.4 Hz, 
2H, CH2=CHCH2O), 5.13 – 5.28 (m, 2H, CH2=CHCH2O), and 5.82 – 5.96 (m, 1H, 
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 CH2=CHCH2O)] was provided by Clariant. Anhydrous magnesium sulfate (MgSO4) and 
glass microscope slides (75 mm x 25 mm x 1 mm) were purchased from Fisher. PEO 
mono methyl ether [Mn = 750 g/mol per manufacturer’s specifications, Mn = 736 g/mol 
per 1H NMR end group analysis; 1H NMR (300 MHz, CDCl3, δ): 3.37 (s, 3H, OCH3) 
and 3.53 – 3.73 (m, 64H, OCH2CH2)], sodium hydride (NaH; 60 wt% in mineral oil), 
allyl bromide, RhCl(Ph3P)3 (Wilkinson’s catalyst), and Pt-divinyltetramethyldisiloxane 
complex (Karstedt’s catalyst) were purchased from Sigma-Aldrich and were used as 
received. Organic solvents were also purchased from Sigma-Aldrich and were dried over 
4 Å molecular sieves prior to use. Medical-grade RTV silicone (MED-1137) was 
purchased from Nusil. Per manufacturer‘s specifications, MED-1137 is comprised of 
α,ω-bis(Si–OH)PDMS, silica (11–21%), methyltriacetoxysilane (<5%), 
ethyltriacetoxysilane (<5%), and trace amounts of acetic acid. The Alexa Fluor 546-dye 
conjugate of human fibrinogen (AF-546 HF; Mw = 340 kDa; lyophilized) was obtained 
from Invitrogen. Phosphate buffered saline (PBS, without calcium and magnesium, pH = 
7.4) was purchased from Cellgro. 
 
3.3.2 Synthesis 
PEO-silane amphiphiles (m = 13; n = 3, 8, and 16) were prepared and 
characterized as previously reported using a two-step hydrosilylation procedure [266]. 
Briefly, α,ω-bis-(SiH)ODMS13 was reacted with vinyltriethoxysilane in a regioselective 
reaction using Wilkinson’s catalyst. Next, the product and each allyl methyl PEO (n = 3, 
8, and 16) were reacted with Karstedt’s catalyst to afford the corresponding PEO-silane 
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 amphiphiles. Allyl methyl PEO (n = 16) was synthesized using established methods 
[266]. 
 
3.3.3 Film Preparation 
Glass microscope slides were sequentially rinsed with dichloromethane (DCM) 
and acetone followed by drying in a 120 °C oven overnight. Silicone films were 
prepared by solvent-casting onto glass microscope slides. Each casting solution 
consisted of 2.0 g of uncured MED-1137 dissolved in 9 mL hexane (25 wt%). Each 
PEO-silane amphiphile was thoroughly mixed into the casting solution with a vortexer at 
the following molar concentrations: 5, 10, 25, 50, and 100 µmol (per 1 g MED-1137). 
Solutions were solvent-cast onto leveled glass microscope slides (1.5 mL per slide) and a 
polystyrene Petri dish cover placed on top to reduce the rate of solvent evaporation and 
prevent bubble formation. Films were allowed to cure one week at room temperature 
(RT) before analysis. Unmodified silicone films (i.e. containing no PEO-silane 
amphiphile) were likewise prepared as controls. 
 
3.3.4 Water Contact Angle Analysis 
Static contact angles (θstatic) of distilled/DI water droplets on silicone films were 
measured at RT using a CAM-200 goniometer (KSV Instruments) equipped with an 
autodispenser, video camera, and drop-shape analysis software (Attension Theta). 
Following deposition of a 5 µL sessile drop of water, the contact angle was iteratively 
measured every 15 seconds over a 5 min period. The reported values at each time point 
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 are the averages and standard deviations of three measurements on different regions of 
the same film. 
 
3.3.5 Protein Adsorption 
AF-546 HF adsorption onto films was measured via fluorescence microscopy. 
On each film, a silicone isolator well (20 mm well diameter, 2 mm depth; McMaster-
Carr) was pressed against the surface, thereby creating a seal which prevented leakage of 
solution from the well. HF solution (100 µg mL-1 in PBS, 0.7 mL) was added to each 
well. (Note: Per manufacturer’s specifications, the AF-546 HF was first dissolved in 0.1 
M NaHCO3 to obtain a 1.5 mg mL-1 solution that was further diluted in PBS to obtain the 
final concentration of 100 µg mL-1.) After 3 h at RT and protected from light, the 
solution was removed and 0.7 mL of fresh PBS was added to each well and then 
removed after 5 min. This process was repeated five times with fresh PBS and lastly 
once with DI water. The protein-exposed films were dried under a stream of air and 
protected from light until imaged. For each film composition, an additional film was 
prepared and likewise rinsed with PBS and DI water, but without exposure to HF 
solution (i.e. soaked 3 h in PBS) in order to correct for the background intensity. 
A FV1000 (Olympus) laser scanning confocal microscope was used for 
quantification of HF adsorption on all silicone films. Imaging conditions (both in 
excitation and collection) were identical for all samples: objective (SPLSAPO 10x 
objective, NA 0.40), laser excitation type and intensity (HeNe 543 nm source), field of 
view and resolution (256 x 256 pixels, 317 x 317 µm field of view), depth (40 slices at 1 
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 µm per slice), slice averaging, and collection (150 µm pinhole, 560 nm long-pass filter 
followed by a 560–660 nm band-pass filter, identical photo-multiplier 
voltages/sensitivities). Data analysis was performed on the FV10-ASW v3.1 software 
suite (Olympus). Each HF-exposed film was imaged in three randomly-selected 
locations within the region of HF solution exposure and aggregate intensities computed. 
These were compared to three images obtained from the analogous surface that had 
similar treatment without HF exposure. Changes in intensity from exposure to HF were 
then obtained and compared, with errors reported as the standard deviation of the three 
measurements. 
 
3.4 Results and Discussion 
3.4.1 Surface Restructuring 
The efficacy of PEO-silane amphiphiles (n = 3, 8, and 16) as SMAs to produce 
protein-resistant silicones was evaluated first in terms of their capacity to undergo water-
driven surface reorganization to form a hydrophilic, PEO-enriched surface. The water-
driven restructuring of PEO to the surface of such bulk-modified silicones has been 
directly observed [222]. In addition, temporally measuring the θstatic of a deposited water 
droplet has been shown to effectively monitor reorganization of PEO to the surface-
water interface [220, 221, 247, 249, 266]. Therefore, the 15 bulk-modified silicones and 
unmodified silicone control (0.14 ± 0.01 mm thick by electronic caliper) were evaluated 
by measuring θstatic of water droplets over a 5 min period. In this way, the rate of 
migration of PEO to the surface-water interface was characterized by how quickly θstatic 
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 decreased (i.e. the rate of increase in surface hydrophilicity). The final value of θstatic (i.e. 
at 5 min) reflected the hydrophilicity achieved through PEO migration. Therefore, lower 
θstatic values were indicative of higher PEO surface coverage which was expected to 
better resist protein adsorption [267]. 
For each PEO-silane amphiphile, the molar concentration had a distinct impact 
on the rate and extent of water-driven surface restructuring of bulk-modified silicones 
and the final hydrophilicity achieved (Figure 3.2). For all concentrations, the bulk-
modified silicones are initially similarly hydrophobic when compared to the unmodified 
silicone (i.e. high θstatic, 0 s), reflecting a lack of PEO at the surface. At the lowest 
concentration (5 µmol), minimal restructuring was observed and the modified silicone 
surfaces remained quite hydrophobic, even at the 5 min time point. At higher 
concentrations, restructuring behavior varied with the PEO-segment length (n). For n = 
3, increasing the concentration from 10 to 100 µmol produced a somewhat small change 
in the achieved hydrophilicity (i.e. θstatic, 5 min = 93 and 76°, respectively). Moreover, at 
each concentration, the majority of the water-driven restructuring occurred by 15 s. 
Despite rapid reorganization, the low number of PEO repeat units limited its capacity to 
increase surface hydrophilicity, even at high concentrations. In stark contrast, n = 8 
restructured at a rapid rate to form hydrophilic surfaces, even at a low concentration of 
10 µmol (θstatic, 5 min = 72°). At higher concentrations, surfaces ultimately became 
exceptionally hydrophilic as characterized by very low θstatic, 5 min values: 25 µmol (38°), 
50 µmol (30°), and 100 µmol (25°). In the case of n = 16, substantial restructuring, 
resulting in a notable increase in surface hydrophilicity, did not occur until the 
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 concentration was 25 µmol or higher. At these concentrations, θstatic, 5 min values were 
higher for n = 16 versus for n = 8, but were lower than for n = 3. Also, the total wt% of 
PEO-silane amphiphile corresponding to the minimum effective molar concentration is 
much less for n = 8 (10 µmol; 1.68 wt%) versus n = 16 (25 µmol; 4.90 wt%) (Table 
3.1). Thus, on the basis of molar concentration and total wt% incorporated into silicone, 
the PEO-silane amphiphile with the intermediate length (n = 8) was the most efficient 
SMA. 
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Figure 3.2. Static water contact angle (θstatic) measured over a 5 min period on bulk-
modified silicone films. For each sample, bars are organized as the time after initial 
drop placement from left to right as follows: 0 s, 15 s, 30 s, 1 min, 2 min, 3 min, 4 
min, and 5 min. Each bar represents the average of measurements made on three 
water droplets on the same sample at the same time point and the error bar is the 
standard deviation. 
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 In addition to the “total molar concentration,” the efficacy of PEO-silane 
amphiphiles as SMAs was also considered in terms of the “PEO concentration” 
expressed in terms of “wt% PEO” (Table 3.1). This permits validation as to whether it is 
the PEO length that gives rise to differences in water-driven surface restructuring 
(Figure 3.2) rather than PEO concentration (independent of length). Because of the 
different molecular weights of the PEO segments (n = 3, 8, and 16) for a given molar 
concentration, the contribution from PEO increases with segment length. For instance, at 
10 µmol PEO-silane amphiphile, the wt% PEO increases in the order: 0.13 (n = 3) < 
0.35 (n = 8) < 0.69 (n = 16). To determine the impact of PEO length versus PEO 
concentration (i.e. wt% PEO), one series of modified silicones is particularly illustrative. 
Silicones prepared with n = 3 (25 µmol), n = 8 (10 µmol), and n = 16 (5 µmol) contain 
the same PEO concentration (0.32 – 0.35 wt%). However, their surface-restructuring 
profiles are quite different and θstatic, 5 min = 88°, 72°, and 106°, respectively. Thus, this 
confirms that PEO length (n) dictates surface restructuring and hydrophilicity, rather 
than simply concentration independent of length. 
Having confirmed the significance of PEO length for surface reorganization, the 
observed results can be explained on the basis of PEO-silane amphiphile steric effects as 
well as solubility in the silicone matrix. For longer PEO segments, steric hindrance may 
reduce surface restructuring potential. Also, in prior work [266], the transparency of 
modified silicones was observed to decrease with PEO length: n = 3 > n = 8 > n = 16. 
Thus, longer PEO segments were more prone to phase separation which would be 
expected to reduce their affinity for water and thus their tendency to migrate to the 
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 surface-water interface. Given the low molecular weight of n = 3, the rapid restructuring 
can be attributed to its low steric hindrance and greater solubility in silicone. However, 
the low number of PEO repeat units reduces its ability to give rise to substantial 
hydrophilicity. For n = 16, its restructuring is relatively inhibited by the chain length as 
well as phase separation within the silicone, requiring higher concentrations (≥ 25 µmol) 
to achieve substantial water-driven hydrophilicity. Thus, n = 8 represents the most 
efficient PEO length, striking a balance between these two effects to achieve 
hydrophilicity at the surface-water interface at only 10 µmol. 
 
3.4.2 Protein Resistance 
Adsorbed fibrinogen plays a well-established role in the initiation of surface-
induced thrombosis [2, 12, 15-17] and is commonly used to evaluate material 
thrombogenicity in vitro [16, 136, 142, 147, 169, 189, 194, 221, 222, 248, 249, 252, 261, 
262]. Oeveren et al. concluded that fibrinogen adsorption was one of the most reliable 
methods to predict thrombogenicity for many materials [268]. Furthermore, silicone was 
found to adsorb the most fibrinogen of all the materials tested, which could explain 
silicone’s high susceptibility to thrombosis. Therefore, fibrinogen adsorption was 
utilized in this study to evaluate the thromboresistance of bulk-modified silicone films. 
Resistance of bulk-modified silicone films to HF adsorption was determined 
using confocal microscopy [220-222, 249, 266]. Following exposure to a solution of 
fluorescently labeled HF (100 µg mL-1; 3 h), the resulting fluorescence intensity of each 
film was measured and normalized to that of the unmodified silicone (Figure 3.3). As 
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 expected, HF adsorption was relatively high for the unmodified silicone. The efficacy of 
the PEO-silane amphiphiles (n = 3, 8, and 16) to reduce protein adsorption onto surfaces 
was impacted by PEO-segment length as well as molar concentration, with protein 
resistance corresponding to their ability to undergo water-driven restructuring to achieve 
hydrophilicity (per Figure 3.2). At all molar concentrations, silicone modified with n = 3 
adsorbed high levels of HF similar to unmodified silicone. This agrees with the observed 
lack of hydrophilicity, even at higher concentrations. Modification of silicone with n = 8 
dramatically reduced HF adsorption at molar concentrations as low as 10 µmol. As the 
concentration was increased, protein adsorption levels remained very low but did not 
substantially change. While increasing the molar concentration beyond 10 µmol led to 
surfaces with greater water-induced hydrophilicity, it did not additionally benefit protein 
resistance. This indicates that the surface presents a sufficient amount of PEO (n = 8) at 
10 µmol. In the case of n = 16, the minimum molar concentration required was 25 µmol, 
with higher concentrations not leading to an improvement in protein resistance. Again, 
this parallels the observation that a 25 µmol concentration is required to achieve water-
induced hydrophilicity. Although hydrophilicity increases somewhat at higher 
concentrations (50 and 100 µmol), they are not necessary for high protein resistance. 
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Figure 3.3. HF adsorption on bulk-modified silicone films as measured by 
fluorescence intensity with confocal microscopy. Each bar represents the average 
and standard deviation of pixel intensity for three images of the sample normalized 
to that of unmodified silicone. Each set of three bars indicates sample fluorescence 
at the given concentration for n = 3 (left), n = 8 (middle), and n = 16 (right). 
 
 
3.5 Conclusions 
To achieve protein resistance and subsequent thromboresistance, a SMA is 
required that can be incorporated into silicones so as to effectively induce water-driven 
PEO-enrichment and hydrophilicity at the surface. PEO-silane amphiphiles comprised of 
a siloxane tether (m) and a PEO segment (n) represent a new class of SMAs with the 
potential to do so. When evaluated previously at a constant molar concentration (50 
µmol per 1 g silicone), PEO-silane amphiphiles (m = 13) dramatically improved protein 
resistance of silicones when n = 8 and 16 but not when n = 3. In this work, the efficacy 
of these PEO-silane amphiphiles (m = 13; n = 3, 8, and 16) was explored in terms of the 
minimum molar concentration required as well as the significance of the PEO-segment 
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 length. Each PEO-silane amphiphile was incorporated into a silicone at 5, 10, 25, 50, and 
100 µmol (per 1 g silicone). Even at higher concentrations, while n = 3 produced rapid, 
water-driven restructuring of modified silicones, it did not achieve appreciable 
hydrophilicity nor protein resistance. In contrast, at a concentration of only 10 µmol, n = 
8 achieved high protein resistance. This represents a total weight concentration of n = 8 
of only 1.68%. While increasing the molar concentration further enhanced water-
induced hydrophilicity, it did not lead to further substantial reductions in protein 
adsorption. Finally, for n = 16, the minimum concentration required for protein 
resistance was found to be higher (25 µmol; 4.90 wt%). When compared on the basis of 
“wt% PEO”, it was determined that PEO length did in fact influence surface 
restructuring and protein resistance, with n = 8 being the most effective. The efficacy of 
n = 8 to undergo water-driven surface migration and induce subsequent protein 
resistance may be attributed to the balance of steric effects and solubility in the silicone 
matrix. Given the low concentration (10 µmol; 1.68 wt%) necessary to invoke a 
substantial reduction in protein adsorption, the n = 8 PEO-silane amphiphile is 
considered to be a potent SMA for silicones. 
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 CHAPTER IV  
PEO-SILANE AMPHIPHILES ADDRESS THE LIMITATIONS ASSOCIATED WITH 
TRADITIONAL SURFACE-MODIFYING ADDITIVES 
 
4.1 Overview 
Poly(ethylene oxide) (PEO)-silane amphiphiles are promising as surface-
modifying additives (SMAs) to improve the protein resistance of silicone for medical 
applications. SMAs have traditionally been associated with significant limitations, 
namely leaching and an inability to adequately repopulate at the surface after material 
abrasion due to poor surface restructuring ability. In this work, key structural features of 
PEO-silane amphiphiles were probed to address those limitations. PEO-silane 
amphiphiles with two oligodimethylsiloxane (ODMS) tether lengths (PEO8-ODMSm-
triethoxysilane, m = 13 and 30) were evaluated and compared to analogous diblock 
(PEO8-ODMSm) and triblock (PEO8-ODMSm-PEO8) SMA controls. For all SMA 
formulations, bulk-modified silicones were found to undergo excellent water-driven 
surface restructuring that persisted even after material abrasion. Leaching from bulk-
modified silicones left in water for two weeks was minimized by using the m = 30 PEO-
silane amphiphile and diblock SMAs. Those two SMAs also caused the smallest increase 
in silicone water uptake. These results indicate that the crosslinking group 
(triethoxysilane) does not impart a significant benefit if the ODMS length is sufficiently 
long. Also, the triblock SMA structures did not improve silicone wettability substantially 
despite having twice the PEO content of respective analogues. 
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 4.2 Introduction 
Despite favorable mechanical and chemical properties [103, 104], a major 
limitation of silicone for implantable medical devices is its poor blood compatibility 
[106]. Due to its hydrophobic nature [228, 229], when silicone is brought into contact 
with blood, it rapidly fouls with plasma proteins (e.g. fibrinogen [268]) that induce 
platelet adhesion and activation [2, 13]. This leads to thrombus formation that, for 
devices such as dialysis catheters, can cause dysfunction, obstruct blood flow, and 
facilitate infection [25-29]. Therefore, silicone modification strategies that can prevent 
protein adsorption and subsequent thrombosis are of significant interest. 
Coatings comprised of poly(ethylene oxide) (PEO) [or poly(ethylene glycol) 
(PEG)] [138, 147, 148] or zwitterionic polymers [183, 185, 193, 197] have been 
proposed to improve silicone protein resistance. It is theorized that these polymers 
effectively prevent biomolecule adsorption via minimization of interfacial free energy 
[128] and formation of a repulsive hydration layer [159]. The excellent protein resistance 
of PEO and zwitterionic coatings has been thoroughly demonstrated in vitro when 
coated onto model substrates such as gold [140-142, 186-192], glass [145, 146, 184], 
and silicon wafer [151-153, 194, 195]. Unfortunately, evidence of their efficacy on 
polymer substrates in vivo is limited and a number of studies have observed poor or 
inconsistent efficacy [169-171, 176, 199, 200]. This may be attributed to the limitations 
of coating techniques. 
Physical adsorption techniques, while quite simple (e.g. dip-coating), result in 
coatings with poor adhesive stability that are prone to removal during implantation 
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 [201]. Surface-grafting techniques result in more stable coatings via covalent attachment 
to the substrate. However, such techniques can be quite complex which limits their 
utility. For example, a “graftable” substrate must contain functional groups or initiators 
to which polymers can covalently attach (“graft-to”) or grow from (“graft-from”) [160]. 
Many biomaterials lack these and must be modified accordingly with additional pre-
treatment steps. Also, the efficacy of these coatings is dependent on high graft density 
[144, 164, 165] which can be difficult to establish, particularly with “graft-to” methods. 
Substrate attachment by free chains may be inhibited due to steric blocking of 
attachment sites by other grafted chains [121]. High graft density can also be difficult to 
maintain. For example, on silicone, surface grafted PEO chains can migrate into the bulk 
during storage in air (i.e. hydrophobic recovery) which reduces PEO surface coverage 
over time [179]. 
To avoid the complexities associated with surface grafting, PEO has been 
incorporated into silicone via bulk-modification [201, 202]. Bulk-modification with 
zwitterionic polymers may also be possible, but their poor solubility in aprotic solvents 
has limited such efforts [214]. In order to be effective, silicone bulk-modified with PEO 
must undergo microphase separation to achieve the high PEO surface coverage 
necessary prevent protein adsorption. Surface modifying additives (SMAs) have proven 
particularly effective for the bulk-modification of other polymeric biomaterials [210, 
214]. SMAs are typically designed as triblock copolymers (A-B-A) where the end blocks 
(A) are hydrophilic (e.g. PEO) and migrate to the material surface where they confer 
protein resistance while the center block (B) is hydrophobic with affinity for the base 
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 polymer network to improve SMA solubility in the network while also preventing 
leaching. When blended in small quantity with the base polymer, SMAs undergo 
migration either during or after fabrication to the material surface [108]. Despite their 
successful use in a variety of biomaterials [214], there is limited literature describing 
SMAs for improving the protein resistance of silicone. Also, SMAs are associated with 
two major shortcomings [108]. First, low molecular weight SMAs can leach from the 
material under aqueous conditions. Also, due to poor restructuring ability, migration of 
SMAs to the surface may be slow or not occur after fabrication. This means that in the 
event of SMA removal caused by surface abrasion, SMAs from the bulk may be 
incapable of repopulating the material surface in time to prevent protein adsorption. 
Our group has designed a SMA (PEO-silane amphiphile; Figure 4.1) intended to 
specifically improve the protein resistance of a medical-grade, condensation-cure 
silicone elastomer (MED-1137, NuSil). This SMA is a diblock structure (A-B) with PEO 
as the hydrophilic segment (A) and oligodimethylsiloxane (ODMS) as the hydrophobic 
segment (B). This particular SMA includes a triethoxysilane (TEOS) functional group – 
attached to ODMS, opposite PEO (PEO-block-ODMS-TEOS) – that can undergo 
condensation reactions to covalently crosslink with the silicone network to prevent 
leaching. Prior work demonstrated that when the PEO-silane amphiphiles were blended 
into silicone in small quantities (less than 10 wt%) prior to curing, they dramatically 
improved the elastomer’s resistance to fibrinogen adsorption (Chapter III). This was 
attributed to the ability of the PEO-silane amphiphile to undergo rapid migration and 
achieve high PEO surface-coverage when bulk-modified silicone was exposed to 
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 aqueous conditions. The speed and extent of surface restructuring was largely dependent 
on PEO length. An oligomeric length of 8 repeat units was found to achieve the best 
protein resistance with minimal concentration (1.7 wt%). It was also confirmed that the 
ODMS segment (m = 13) dramatically enhanced the ability of PEO to migrate to the 
surface when compared to non-amphiphilic PEO-silane controls (PEO-TEOS) [266]. 
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Figure 4.1. Structures of SMA amphiphiles evaluated in this study. 
 
In this work, PEO-silane amphiphiles were evaluated in terms of their ability to 
overcome the limitations associated with SMAs (i.e. leaching and inadequate abrasion 
recovery). The abilities of the SMAs to efficiently replenish PEO at the silicone surface 
after abrasion were evaluated. Key structural features of the PEO-silane amphiphiles 
were also probed. In order to determine the efficacy of the crosslinker, diblock analogues 
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 (A-B) without TEOS were prepared (Figure 4.1). To determine if there was a benefit to 
the non-crosslinkable, triblock structure (A-B-A) that is most commonly used for SMAs 
[207-211], PEO-ODMS-PEO analogues were also prepared and evaluated. As these 
contain twice the quantity of PEO, these could foreseeably improve silicone wettability 
more effectively. Without the ability to crosslink, both analogues were expected to be 
more susceptible to leaching. As an alternative to crosslinking, a longer ODMS segment 
(m = 30) was also tested for each SMA architecture. This was hypothesized to physically 
reduce leaching of SMAs by decreasing the additive’s solubility in water while 
simultaneously increasing its affinity for the silicone base network. If sufficiently 
effective, the longer tether could obviate the need for chemical crosslinking (TEOS) 
entirely. It has also been shown in previous work that PEO-silane amphiphiles of this 
ODMS length achieve excellent silicone hydrophilicity and protein resistance similar to 
those of m = 13 [223]. 
 
4.3 Materials and Methods 
4.3.1 Materials 
Allyl methyl PEO [Polyglykol AM 450, Mn = 292–644 g mol-1 per 
manufacturer's specifications; Mn = 424 g mol-1 per 1H NMR end group analysis; 1H 
NMR (δ, ppm): 3.35 (s, 3H, OCH3), 3.51–3.66 (m, 32H, OCH2CH2), 4.00 (d, J = 5.4 Hz, 
2H, CH2=CHCH2O), 5.13–5.28 (m, 2H, CH2=CHCH2O) and 5.82–5.96 (m, 1H, 
CH2=CHCH2O)] was kindly provided by Clariant. Octamethylcyclotetrasiloxane, 
vinyltriethoxysilane (VTEOS), Pt-divinyltetramethyldisiloxane complex (Kastedt’s 
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 catalyst) in xylene, and α,ω-bis-(SiH)oligodimethylsiloxane [ODMS13; Mn = 1000–1100 
g mol-1 per manufacturer's specifications; Mn = 1096 g mol-1 per 1H NMR end group 
analysis; 1H NMR (δ, ppm): 0.05–0.10 (m, 78H, SiCH3), 0.19 (d, J = 2.7 Hz, 12H, 
OSi[CH3]2H) and 4.67–4.73 (m, 2H, SiH)] were purchased from Gelest. Triflic acid, 
RhCl(Ph3P)3 (Wilkinson’s catalyst), hexamethyldisilazane (HMDS), and solvents were 
obtained from Sigma-Aldrich. All solvents were dried over 4Å molecular sieves prior to 
use for hydrosilylation reactions and film casting. Glass microscope slides (3” x 1”) 
were purchased from Fisher Scientific. Medical-grade condensation-cure room-
temperature-vulcanizing (RTV) silicone elastomer (MED-1137) was purchased from 
NuSil Technology. 
 
4.3.2 Synthetic Approach 
Reactions were all run under a N2 atmosphere with a Teflon-covered stir bar to 
agitate the mixture. Chemical structures were confirmed with nuclear magnetic 
resonance (NMR) spectroscopy using a Mercury 300 MHz spectrometer operating in the 
Fourier transform mode and using CDCl3 as the standard. Syntheses of α,ω-bis-
(SiH)oligodimethylsiloxane [ODMS30; Mn = 2338 g mol-1 per 1H NMR end group 
analysis) and PEO-silane amphiphiles (m = 13 and 30) were carried out following 
previously-established procedures [223, 266]. 
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 4.3.2.1 Synthesis of Diblock Amphiphiles 
Diblock amphiphiles were prepared using a Wilkinson’s-catalyzed regioselective 
hydrosilylation procedure. Allyl methyl PEO8 (Mn = 424 g mol-1) and ODMSm (1:1 
molar ratio) were dissolved in toluene in a sealed round bottom flask with 10 mg 
Wilkinson’s catalyst and heated to 80 °C. After 16 h, the catalyst was removed from the 
reaction mixture by adding activated charcoal and heating at 90 °C for 2 h. The mixture 
was then cooled to room temperature (RT) and filtered to remove the charcoal. After 
filtration, the volatiles were removed under reduced pressure to yield colorless polymer 
liquid. 
 
Diblock Amphiphile (m = 13). Allyl methyl PEO8 (3.09 g, 7.29 mmol) and 
ODMS13 (8.00 g, 7.30 mmol) and Wilkinson’s catalyst were reacted in 50 mL toluene. 
The product (8.98 g, 81% yield) was obtained using the described procedure. 1H NMR 
(δ, ppm): 0.03–0.10 (m, 84H, SiCH3), 0.18 (d, J = 2.7 Hz, 6H, OSi[CH3]2H), 0.46–0.55 
(m, 2H, SiCH2CH2CH2), 1.51–1.67 (m, 2H, SiCH2CH2-CH2), 3.38 (s, 3H, OCH3), 3.41 
(t, J = 7.1 Hz, 2H, SiCH2CH2CH2), 3.50–3.73 (m, 32H, CH2CH2O), and 4.67–4.73 (m, 
1H, SiH). 
 
Diblock Amphiphile (m = 30). Allyl methyl PEO8 (2.48 g, 5.85 mmol) and 
ODMS30 (13.79 g, 5.86 mmol) and Wilkinson’s catalyst were reacted in 50 mL toluene. 
The product (13.00 g, 80% yield) was obtained using the described procedure. 1H NMR 
(δ, ppm): -0.08–0.15 (m, 186H, SiCH3), 0.18 (d, J = 2.7 Hz, 6H, OSi[CH3]2H), 0.47–
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 0.55 (m, 2H, SiCH2CH2CH2), 1.52–1.66 (m, 2H, SiCH2CH2-CH2), 3.38 (s, 3H, OCH3), 
3.41 (t, J = 7.4 Hz, 2H, SiCH2CH2CH2), 3.52–3.69 (m, 32H, CH2CH2O), and 4.68–4.72 
(m, 1H, SiH). 
 
4.3.2.2 Synthesis of Triblock Amphiphiles 
Triblock amphiphiles were prepared using a Karstedt’s-catalyzed hydrosilylation 
procedure. Allyl methyl PEO (Mn = 424 g mol-1) and ODMSm (2:1 molar ratio) were 
dissolved in toluene in a sealed round bottom flask with Karstedt’s catalyst and heated to 
80 °C. After 16 h, the catalyst was removed by adding activated charcoal to the reaction 
mixture and heating at 90 °C for 2 h. The mixture was then cooled to RT and filtered. 
The volatiles were then removed under reduced pressure to yield the colorless polymer 
product. 
 
Triblock Amphiphile (m = 13). Allyl methyl PEO8 (3.21 g, 7.57 mmol) and 
ODMS13 (4.15 g, 3.79 mmol) and Karstedt’s catalyst (25 µL) were reacted in 30 mL 
toluene. The product (3.35 g, 46% yield) was obtained using the described procedure. 1H 
NMR (δ, ppm): 0.05–0.09 (m, 90H, SiCH3), 0.47–0.54 (m, 4H, SiCH2CH2CH2), 1.54–
1.66 (m, 4H, SiCH2CH2-CH2), 3.37 (s, 6H, OCH3), 3.41 (t, J = 7.2 Hz, 4H, 
SiCH2CH2CH2), and 3.52–3.68 (m, 64H, CH2CH2O). 
 
Triblock Amphiphile (m = 30). Allyl methyl PEO8 (1.49 g, 3.51 mmol) and 
ODMS30 (4.12 g, 1.75 mmol) and Karstedt’s catalyst (25 µL) were reacted in 30 mL 
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 toluene. The product (3.67 g, 65% yield) was obtained using the described procedure. 1H 
NMR (δ, ppm): -0.02–0.17 (m, 192H, SiCH3), 0.46–0.55 (m, 4H, SiCH2CH2CH2), 1.52–
1.65 (m, 4H, SiCH2CH2-CH2), 3.37 (s, 6H, OCH3), 3.41 (t, J = 7.2 Hz, 4H, 
SiCH2CH2CH2), and 3.52–3.68 (m, 64H, CH2CH2O). 
 
4.3.3 Silicone Film Preparation 
Glass microscope slides were sequentially rinsed with DCM and acetone 
followed by drying in a 120 °C oven overnight. Casting solutions were prepared by 
mixing 2 g uncured MED-1137 with 6 g (9 mL) hexane and mixing with a vortexer until 
a homogenous solution was obtained. For modification of silicone, the PEO-silane, 
diblock, and triblock amphiphiles were added to individual casting solutions at 50 µmol 
of SMA per 1 g silicone and mixed thoroughly. Solutions were solvent-cast onto leveled 
glass slides (1.5 mL per slide [2.0 mL for leaching study]) in a covered polystyrene Petri 
dish. The films were allowed to cure for one week at RT and then promptly used for 
designated analyses. 
 
4.3.4 Characterization 
4.3.4.1 Water-Driven Surface Restructuring 
Water-driven surface restructuring of bulk-modified silicone was characterized 
with static water contact angle (θstatic) using a CAM-200 goniometer (KSV Instruments) 
equipped with an autodispenser, video camera, and drop-shape analysis software 
(Attension Theta). For each measurement, a 5 µL DI water droplet was placed on the 
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 film and θstatic was iteratively measured over a 5 min period. Afterwards, the film was 
dried under a stream of air. The reported θstatic values are an average and standard 
deviation of three measurements each made on different areas of the same film. 
Water-driven surface restructuring of bulk-modified silicone was also evaluated 
immediately after abrasion. A razor blade was used to cut away a thin layer from the 
surface of the film. θstatic was then measured on the freshly exposed surface. This process 
was repeated on three different regions of each film to yield an average and standard 
deviation as reported. 
Changes in water-driven surface restructuring of bulk-modified silicone were 
measured during and after water and air equilibration. Two of each film type were 
prepared and one week after casting, θstatic was measured on both. Next, one film was 
submerged in ~30 mL DI water (water-equilibrated) while the other was left in air (air-
equilibrated), both in a polystyrene Petri dish. The film in water was removed after 2 h 
and briefly dried under stream of air before measuring θstatic. After making three 5-min 
θstatic measurements, the film was resubmerged in fresh DI water. This process was 
repeated at 6 h, 24 h, 48 h, 72 h, 6 days, 10 days, and 14 days after the initial water 
submersion. At the 14th day, each film was dried under reduced pressure at 50 °C 
overnight and a final θstatic was measured. The film left in air was measured again 7 and 
14 days after the initial measurement. 
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 4.3.4.2 Leaching 
For leaching studies, six of each film type were prepared. Using a razor, silicone 
films were removed from the glass slide and uniquely marked for identification 
purposes. The mass of each film was then measured and recorded. For each film type, 
three films were submerged in 30 mL DCM and three were submerged in 30 mL DI 
water, both in sealed glass jars. After one week, the solution in each jar was replaced 
with 30 mL fresh solvent. One week later, the films were removed and dried overnight 
under reduced pressure. The final mass of each film was then measured and was used to 
calculate the mass loss ratio of bulk-modified films as follows: 
 
Mass Loss Ratio = (FML – UML) / MA  (Equation 4.1) 
 
where FML is the bulk-modified film percent mass loss, UML is the unmodified film 
percent mass loss, and MA is the percent mass of additive. Percent mass loss was 
calculated using established methods [208]. The mass loss ratio was useful in estimating 
what portion of the mass loss was attributable to the additive of bulk-modified films by 
accounting for differences in additive weight concentrations and the mass loss that 
occurs in silicone without the SMAs. 
 
4.3.4.3 Water Uptake 
Three of each film type on glass slides were submerged in ~30 mL DI water in 
individual polystyrene Petri dishes. After 24 h, the films were removed from water and 
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 dried with stream of air and dabbed dry with a paper towel. The water content of the film 
was then measured by thermal gravimetric analysis (TGA). A 20 ± 2 mg segment of film 
was removed from the glass slide by razor blade and placed in a platinum TGA pan. 
Using a TA Instruments Q50, weight loss was measured as the sample was heated from 
RT to 150 °C at a rate of 10 °C min-1. Water loss was observed as a peak in the mass loss 
derivative curve that occurred between RT and approximately 100 °C. Water content of 
each film was then determined by measuring the percent mass loss over the bounds of 
that peak. After each measurement, the films were resubmerged in fresh DI water. TGA 
measurements were repeated again 7 and 14 days after initial submersion in water. The 
reported values are the average water contents and standard deviation of three 
identically-prepared films at the same submersion time. This technique provided 
accurate and reproducible measurements that were not influenced by leaching-caused 
changes in mass as may occur with other techniques [208]. 
 
4.4 Results and Discussion 
4.4.1 Water-Driven Surface Restructuring 
Water-driven restructuring of PEO to the surface of bulk-modified silicone films 
was characterized with static water contact angle measurements. Significant decreases in 
contact angle (i.e. increasing hydrophilicity) were attributed to increasing PEO chain 
density at the surface as the migrating hydrophilic polymer enhanced surface wettability. 
Figure 4.2 shows the five-minute θstatic profiles for water droplets left on each of the 
silicone films. As expected, the unmodified silicone remained hydrophobic [260] and the 
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 contact angle changed only slightly during the measurement period, indicating minimal 
surface restructuring. All of the bulk-modified films achieved rapid and substantial 
water-induced hydrophilicity, but some of the profiles were distinct based on the 
structure of the SMA. Pronounced differences were observed between SMAs of siloxane 
length, m = 13. For those SMAs, the diblock structure achieved the greatest 
hydrophilicity (θstatic, 5min = 6°) and the speed and extent of PEO migration was reduced 
when SMAs were crosslinked or changed to a triblock architecture (θstatic, 5min = 27° & 
21°, respectively). Crosslinking essentially anchors the PEO-silane amphiphiles to the 
silicone network, so it stands to reason that this would reduce its ability to migrate to the 
surface. However, considering that the triblock-modified silicone contained twice the 
quantity of PEO and the SMA was uncrosslinked, it was remarkable that the 
hydrophilicity was reduced compared to the diblock structure. This could be due to the 
short ODMS which is insufficient for improving the solubility of that amount of PEO 
within silicone. In agreement, the triblock architecture became more effective when the 
ODMS length was increased to m = 30 (θstatic, 5min = 17°). Regardless of crosslinking, the 
m = 30 diblock SMA structures exhibited restructuring behavior and hydrophilicity that 
were similar to each other (θstatic, 5min = 26° [uncrosslinked] & 30° [crosslinked]) and to 
that of the m = 13 PEO-silane amphiphile. These results indicate that increasing the 
length of ODMS to m = 30 has a similar effect on restructuring as chemically 
crosslinking with TEOS. Therefore, at the longer ODMS length (m = 30), TEOS had 
little effect on restructuring. 
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Figure 4.2. θstatic measured over a five minute period on bulk-modified silicone films 
one week after casting. Bars are organized as the time after initial drop placement 
from left to right as follows: 0 s, 15 s, 30 s, 1 min, 2 min 3 min, 4 min, and 5 min. 
(XL: ‘crosslinked’ PEO-silane amphiphile) 
 
Water-driven surface restructuring was also evaluated immediately after 
inflicting abrasion with a razor. Figure 4.3 shows the five-minute θstatic profiles 
measured on the freshly exposed surfaces of each film. The film that changed the most 
after abrasion was the unmodified silicone control which became more hydrophilic 
(Δθstatic, 5min ≈ -18°). All of the bulk-modified silicone films maintained the ability to 
become hydrophilic and were nearly indistinguishable in restructuring behavior versus 
their original profiles. The only exception was the m = 30 triblock SMA film which 
restructured faster and became more hydrophilic (Δθstatic, 5min ≈ -12°). This seems to 
imply that there’s a higher concentration of that SMA in the bulk than near the surface 
which would enhance the apparent water-driven restructuring when the film surface is 
removed. However, this would not be expected to adversely affect protein resistance. 
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Figure 4.3. θstatic measured over a five minute period on freshly exposed surface of 
bulk-modified silicone films after cutting away top layer with a razor. Bars are 
organized as the time after initial drop placement from left to right as follows: 0 s, 
15 s, 30 s, 1 min, 2 min 3 min, 4 min, and 5 min. (XL: ‘crosslinked’ PEO-silane 
amphiphile) 
 
While equilibrating bulk-modified silicone films in water for two weeks, they 
were periodically removed and quickly dried under a stream of air to make θstatic 
measurements. By the second week, all of the water-soaked films achieved reduced 
hydrophilicity with contact angles ranging between 35 and 45° (Figure 4.4). The θstatic, 
5min was at least 15° greater than the initial measurements for all films except that 
modified with the m = 30 PEO-silane amphiphile (Δθstatic, 5min ≈ 8°). The two SMAs that 
best improved silicone hydrophilicity initially were most adversely affected by water 
conditioning: θstatic, 5min for m = 13 diblock and m = 30 triblock amphiphile films 
increased by approximately 30° and 20° respectively. The apparent loss in SMA 
restructuring ability was hypothesized to be caused by two factors: (1) leaching of the 
SMAs under aqueous conditions which would reduce their concentration in the silicone 
bulk and diminish hydrophilicity accordingly (Chapter III) and (2) water uptake by the 
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 films which would inhibit SMA surface migration by reducing the driving force of PEO 
for the surface-water interface. Of these two explanations, SMA leaching would be 
expected to cause a permanent change in restructuring behavior whereas changes caused 
by water uptake could be reversed by drying the films. 
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Figure 4.4. θstatic measured at “5 min” time point after drop placement on bulk-
modified silicone films during two-week water equilibration study. (XL: 
‘crosslinked’ PEO-silane amphiphile) 
 
To determine if the observed hydrophilicity loss was due to water uptake, films 
were dried under vacuum at 50°C overnight and θstatic measurements were made 
afterwards. Surface restructuring profiles were compared for each film after curing 
(initial), after two weeks in water (water equilibrated), and after drying (dried) (Figure 
4.5). It was observed on most of the films that after drying, the water-driven 
restructuring behavior was very similar to initial measurements. The recovery of 
hydrophilicity indicated that water uptake was the primary cause of changes that 
occurred with water conditioning. The only exception was silicone modified with the m 
= 13 diblock amphiphile on which θstatic, 5min reached 20° after drying compared to 7° 
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 before water conditioning. This irreversible change in restructuring was considered 
indicative of substantial SMA leaching compared to the other bulk-modified films. The 
water-driven restructuring profile of the m = 30 triblock amphiphile film also changed 
after drying. Similar to the abrasion results, it restructured faster than the original film. 
These results are not indicative of leaching. It is hypothesized instead that there is a 
permanently higher concentration of SMA near the surface than before water-
equilibration.  
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Figure 4.5. θstatic measured over a five minute period on bulk-modified silicone films 
after one week curing in air (Initial), two weeks soaked in water (Water 
Equilibrated), and drying under vacuum and elevated temperature (Dried). Bars 
are organized as the time after initial drop placement from left to right as follows: 0 
s, 15 s, 30 s, 1 min, 2 min 3 min, 4 min, and 5 min. 
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 4.4.2 Leaching 
To detect SMA leaching, bulk-modified silicone films were soaked in DI water 
and DCM for two weeks and the resulting changes in mass were measured. The percent 
mass loss of each film is reported in Figure 4.6 as well as the mass loss ratios of bulk-
modified films. It can be seen that the unmodified silicone films did undergo 
measureable mass loss, even in water. Therefore, for any bulk-modified films that 
underwent similar mass loss, the corresponding SMA was considered resistant to 
leaching. The mass loss ratio equation accounts for this by subtracting the measured 
mass loss of unmodified silicone from the mass loss of each bulk-modified film. The 
equation then divides by the percent mass of SMA in the given film to account for 
differing weight concentrations of the various structures. In water, films modified with m 
= 13 SMAs experienced the most mass loss, greatest of which was the non-crosslinkable 
diblock structure. It therefore appears that because of the diblock structure, small tether 
length, and inability to crosslink, that particular SMA is the least stable within silicone 
under aqueous conditions. These results explain the permanent change in water-driven 
restructuring behavior observed on silicone modified with the m = 13 diblock SMA. It 
can be seen by comparing the mass loss ratio values that the m = 30 amphiphiles were 
the most resistant to leaching in water. As PEO-silane amphiphile synthesis is more 
complex, the uncrosslinkable m = 30 diblock SMA appears to be the best structure for 
use in silicone. 
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Figure 4.6. Film mass loss (left) and mass loss ratio (right) of bulk-modified silicone 
films after soaking in water (above) and DCM (below) for two weeks. Each bar 
represents the average percent mass loss of three identically-prepared films and the 
error bar is the standard deviation. (XL: ‘crosslinked’ PEO-silane amphiphile) 
 
Also shown in Figure 4.6 are the mass loss results for silicone films soaked in 
DCM. As this is a good solvent for silicone as well as the SMAs, it caused film swelling 
and extraction of high quantities of uncrosslinked material. The mass losses for all bulk-
modified films were significantly greater than that of unmodified silicone. The PEO-
silane amphiphiles were found to undergo less mass loss than their respective 
uncrosslinkable diblock analogues, but still increased the sol content of silicone. 
Therefore, TEOS may not effectively form covalent bonds with the silicone network to 
ensure complete crosslinking of PEO-silane amphiphiles. The TEOS could also interfere 
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 with the elastomer crosslinking which would cause mass loss consisting of uncrosslinked 
silicone. 
 
4.4.3 Water Uptake 
The water contents of water-conditioned films were measured by TGA during 
and after a two-week soaking period (Figure 4.7). It can be seen that all of the bulk-
modified films absorbed significantly more water than unmodified silicone films within 
24 h. It is hypothesized that SMAs within the hydrophobic silicone network undergo 
phase separation, forming micelle-like structures with a hydrophilic PEO core that can 
store water [269]. Therefore, it was expected that the quantity of water uptake would be 
related to the amount of PEO and the ability of the SMAs to form stable hydrophilic 
domains. After two weeks, all m = 13 SMAs caused relatively large increases to silicone 
water uptake (>3 wt%). At that tether length, the PEO-silane amphiphile took up the 
least water, perhaps due to an inability of the immobilized SMA to effectively transport 
water from the silicone surface to the bulk. Despite a higher PEO content, the m = 13 
triblock-modified silicone took up less water than silicone modified with the diblock 
amphiphile. This is likely due to the higher portion of PEO to ODMS in each chain 
which could impair micelle formation. Furthermore, this would explain why the triblock 
amphiphile SMAs caused greater water uptake when the ODMS length was increased to 
m = 30. The m = 30 PEO-silane and diblock amphiphiles both caused the lowest silicone 
water uptake (1 wt%). This may be explained by the improved solubility of those SMAs 
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 in silicone due to the longer ODMS tether which would reduce their tendency to phase 
separate and hydrophilic domains for water storage. 
 
m = 13 m = 30
0
1
2
3
4
5
6
7
8
unmodified XL diblock triblock XL diblock triblock
W
ei
gh
t%
 W
at
er
 
Figure 4.7. Percent water composition by weight of bulk-modified silicone films 
soaked in water for two weeks. For each film, bars are organized as the time 
underwater prior to measurement from left to right as follows: 24 h, 1 week, and 2 
weeks. (XL: ‘crosslinked’ PEO-silane amphiphile) 
 
Confirmation of water uptake explains the reversible changes in water-driven 
surface restructuring that were observed on all bulk-modified silicones during water 
conditioning. However, there is no apparent correlation between the amount of water 
uptake and the final water-driven surface restructuring behavior. It is possible that 
swelling and changing mechanical properties caused by water uptake would be 
undesirable for medical device materials. Significant swelling of films is likely to 
exacerbate SMA leaching. Water uptake is also undesirable for any elastomer 
crosslinked by condensation reactions (i.e. MED-1137) which are reversible in the 
presence of water. Based on these results, the m = 30 PEO-silane and diblock 
amphiphiles would be best suited for medical silicones due to their relatively low water 
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 uptake. If even lower water content is desired, smaller quantities of SMA may be used to 
reduce water uptake without impairing protein resistance (Chapter III). 
 
4.5 Conclusions 
Silicones used for implantable medical devices are often compromised by their 
poor resistance to protein adsorption which causes thrombus formation and infection. 
When incorporated into a medical-grade silicone elastomer, PEO-silane amphiphiles act 
as SMAs that undergo water-driven surface restructuring when the silicone is exposed to 
aqueous/biological conditions. A particular formulation of PEO-silane amphiphile (m = 
13, n = 8) had previously been shown to effectively reduce protein adsorption on silicone 
[266]. In this work, the same PEO-silane amphiphile was evaluated in terms of its ability 
to overcome the limitations typically associated with SMAs (i.e. leaching and poor 
abrasion recovery). To reduce leaching, PEO-silane amphiphiles have been synthesized 
with TEOS which is meant to covalently crosslink with the silicone network. When 
compared to an analogous diblock amphiphile without TEOS, it was found that the 
crosslinking group reduced leaching of bulk-modified silicone films. However, it was 
determined that leaching could be reduced more effectively by increasing the size of 
ODMS to m = 30, at which length the presence of TEOS became almost inconsequential. 
Sol content following extraction with DCM was found to increase for silicones prepared 
with SMAs, even those based on TEOS crosslinkable groups. Furthermore, the TEOS 
did not appear to significantly affect water uptake with m = 30 amphiphiles. Analogous 
triblock amphiphiles (m = 13 & 30), representative of traditional SMAs, were prepared 
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 and similarly evaluated for comparison. They underwent similar restructuring to the 
diblock structures and best-resisted leaching at the longer ODMS length, but were more 
prone to water uptake. For all of the tested SMAs, bulk-modified silicone films exhibited 
little to no change in their water-driven surface restructuring behavior following surface 
abrasion. In conclusion, the m = 30 PEO-silane and diblock amphiphiles are similarly 
well-suited as silicone SMAs. Presumably, because the diblock amphiphile is 
significantly simpler to synthesize, it would be preferable in future work. As 
crosslinking does not appear to be necessary, non-crosslinkable diblock SMAs may also 
be suitable for any medical-grade silicone elastomer, regardless of curing chemistry. 
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 CHAPTER V  
CONCLUSIONS 
 
5.1 Conclusions 
Surface-induced thrombosis is a major limitation of silicone usage in blood-
contacting medical devices. Due to its hydrophobic nature, silicone adsorbs high levels 
of plasma proteins which subsequently initiate thrombus formation. Antithrombotic 
drugs are commonly used to address this, but they are associated with bleeding 
complications, comorbidities, and limited efficacy. Representing a safer alternative is 
modification of silicone with poly(ethylene oxide) (PEO), which prevents thrombosis by 
effectively inhibiting protein adsorption. This hydrophilic polymer is highly effective 
when present at the material-biological interface at sufficient concentrations. 
Unfortunately, efforts to render polymeric materials thromboresistant with PEO have 
been met with disappointing and inconsistent results [169-171]. It is hypothesized that 
conventional PEO-silanes, when used as bulk-modifying additives (SMAs) for silicone, 
are unable to undergo efficient water-driven migration to the surface-biological interface 
which results in poor protein resistance. 
In this work, PEO-silane amphiphiles (α(EtO)3Si-(CH2)2-oligodimethyl-
siloxane13-block-poly(ethylene oxide)n-OCH3) (n = 3, 8, and 16) were prepared as SMAs 
to effectively improve PEO-enrichment at the surface-water interface, and hence protein 
resistance, of silicone. The hydrophobic, flexible oligodimethylsiloxane (ODMS) tether 
served to enhance the solubility and mobility of PEO within the silicone network while 
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 the triethoxysilane (TEOS) group formed chemical crosslinks with the network to reduce 
leaching. 
In Chapter II, PEO-silane amphiphiles with three different PEO-segment lengths 
(n = 3, 8, and 16) were evaluated and compared to analogous PEO-silanes having no 
ODMS tether (i.e. PEO-controls). When grafted onto a model substrate absent of surface 
restructuring effects, the inherent protein resistance of PEO-silane amphiphiles was 
reduced versus the PEO-controls. It was confirmed with water contact angle analysis that 
the siloxane tether increased the relative hydrophobicity of the grafted PEO-silane 
amphiphiles which explained the increase in protein adsorption. When incorporated into 
a medical-grade silicone, the PEO-silane amphiphiles exhibited rapid, water-driven 
surface migration but the PEO-controls did not. PEO-silane amphiphiles n = 8 and 16 
produced the greatest enhancement in water-induced surface hydrophilicity and protein 
resistance. Thus, these results demonstrated that the efficacy of PEO-silanes as SMAs 
for silicones could be dramatically improved via incorporation of an ODMS tether and 
tailoring the PEO-segment length. Furthermore, they revealed potential limitations with 
using model substrates to evaluate the protein resistance of PEO-silanes intended for 
polymeric materials. 
The main purpose of Chapter III was to determine the efficacy of PEO-silane 
amphiphiles (n = 3, 8, and 16), in terms of the minimum required molar concentration in 
silicone, to form a PEO-enriched surface and resist protein adsorption. The significance 
of PEO-segment length was also examined. Each PEO-silane amphiphile was blended 
into silicone at five different molar concentrations (5, 10, 25, 50, and 100 µmol per 1 g 
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 silicone). For each PEO-segment length, the extent of water-driven restructuring and 
resulting hydrophilicity increased with increasing molar concentrations. For n = 3, 
restructuring occurred quickly, but produced a relatively small change in silicone 
hydrophilicity due to its short PEO length. In contrast, n = 8 and n = 16 both led to rapid, 
water-driven surface restructuring but n = 8 did so more efficiently, requiring only 10 
µmol (1.68 wt%) versus 25 µmol (4.90 wt%). Protein adsorption results correlated well 
with water-driven surface restructuring in that only n = 8 and 16 (at the minimum molar 
concentrations) were able to significantly reduce protein adsorption. When compared on 
the basis of “wt% PEO,” it was determined that PEO length did influence surface 
restructuring and protein resistance and that n = 8 was the most effective. The efficacy of 
n = 8 to induce water-driven surface migration of PEO and subsequent protein resistance 
may be attributed to the balance of steric effects and solubility in the silicone matrix. It 
was therefore concluded that the PEO-segment length of n = 8 was optimal for PEO-
silane amphiphiles (m = 13) as a silicone SMAs. 
In Chapter 4, the efficacy of PEO-silane amphiphiles were evaluated in terms of 
their ability to minimize leaching from the silicone and maintain surface hydrophilicity 
after abrasion or extended exposure to water. Specifically, a diblock versus triblock 
architecture was examined as well as the presence or absence of a crosslinkable silane 
end group. While few are reported specifically for silicones, conventional SMAs possess 
a triblock architecture, lack crosslinkability, and are higher in molecular weight. 
Analogous to PEO-silane amphiphiles, diblock amphiphiles were prepared without 
TEOS (PEOn-ODMSm) to determine the efficacy of the crosslinker in preventing 
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 leaching. Both the PEO-silane and diblock amphiphiles were prepared with a single PEO 
length (n = 8) and two ODMS tether lengths (m = 13 and 30). It was hypothesized that 
the longer tether could prevent leaching by simultaneously decreasing the amphiphile’s 
solubility in water and increasing its affinity for the base polymer. Analogous triblock 
amphiphiles (PEO8-ODMSm-PEO8) were also prepared which were representative of 
conventional SMAs for comparison. All amphiphiles were incorporated into the 
condensation-cure silicone elastomer at the same molar concentration (50 µmol per 1 g 
silicone) and were found to undergo excellent water-driven surface restructuring. This 
restructuring was not reduced with surface abrasion for any samples. Of all the SMAs 
tested, the m = 30 PEO-silane and diblock amphiphiles were the most resistant to 
leaching in water over a two-week period. This indicated that the m = 30, n = 8 PEO-
silane and diblock amphiphiles were most ideal as silicone SMAs because they 
addressed both of the SMA-associated limitations (i.e. abrasion recovery and leaching). 
It was also determined that PEO-silane amphiphiles were not well-crosslinked to the 
silicone elastomer. Therefore, TEOS does not appear to be effective nor necessary as a 
crosslinking group for preventing aqueous leaching of PEO-silane amphiphiles, provided 
the ODMS segment is sufficiently long. In conclusion, the diblock amphiphile would be 
preferable for future work as it performs similarly to the PEO-silane amphiphile as a 
SMA, but is considerably easier to synthesize. 
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 5.2 Future Directions 
The curing mechanism of the silicone elastomer tested in this work was based on 
condensation chemistry; however, other chemistries are also used to crosslink room-
temperature-vulcanizing (RTV) silicones. Common strategies for silicone curing employ 
addition (hydrosilylation, Pt-cure) and free-radical ([meth]acrylate polymerization, UV-
cure) chemistries. Therefore, the finding that chemical crosslinking may not be 
necessary to prevent SMA leaching has important implications. The diblock amphiphile 
(m = 30, n = 8) that restructured effectively could potentially be incorporated into any 
silicone elastomer, regardless of curing chemistry, without concern for leaching. Without 
a crosslinking group, the amphiphile synthesis is simplified considerably as a second 
hydrosilylation reaction is not required. In future studies, the same PEO-silane and 
diblock amphiphiles tested in Chapter IV will be evaluated in Pt- and UV-cure silicone 
elastomers (Figure 5.1). The effects of crosslinking will again be examined. The diblock 
amphiphile is expected to covalently crosslink into Pt-cure silicone by nature of the 
hydrosilane-terminated ODMS tether. For that elastomer, PEO-silane amphiphiles can 
serve as the uncrosslinkable diblock amphiphile control. To crosslink with UV-cure 
silicones, an analogous methacrylate-functionalized diblock amphiphile has been 
prepared (see Appendix). It is possible that the lengths of the PEO and ODMS segments 
that were found to be optimal in this work may not be so within different silicone 
elastomers due to differences beyond curing chemistry (e.g. crosslinking density and 
filler content). Fortunately, this work lays out a basis for methodologies to optimize 
SMA concentration and formulation and can be reemployed in future studies if 
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 necessary. In future work, it will also be important to confirm that each of the modified 
silicones is specifically resistant to thrombus formation with whole blood studies. 
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Figure 5.1. Derivatives of PEO-silane amphiphiles for crosslinking into silicone 
elastomers with different curing chemistries. 
 
The main objective of this dissertation has been to develop a silicone elastomer 
for implantable medical devices that resists protein adsorption and subsequent 
thrombotic complications. However, there are other applications for which fouling-
resistant silicones are desirable, particularly in the maritime industry. On ship hulls and 
other marine structures, the adhesion of marine organisms such as diatom slimes, algae, 
and barnacles (i.e. biofilms) is considered problematic. Biofilm formation creates 
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 hydrodynamic drag as vessels move through water which increases fuel consumption 
rates [270]. The increased fuel consumption, as well as hull cleaning and repainting, 
represent significant financial burdens [270]. Silicone elastomers are commonly applied 
to hulls as foul-release (FR) coatings [227]. These coatings weaken the adhesion strength 
of biofouling organisms which facilitates their removal [227, 271, 272], but silicone’s 
hydrophobicity increases the amount of fouling that occurs [229]. Modification with 
PEO could therefore improve the performance of marine silicones by enhancing surface 
wettability. In recent work by Hawkins and coworkers [247], silicone modified with the 
m = 13 and n = 8 PEO-silane amphiphile was found to resist marine bacterial and diatom 
biofilm formation. Additionally, the modified silicone was coated onto fiberglass panels 
and left in the Atlantic Ocean for 6 weeks and effectively prevented slime formation. 
These early results are promising and the use of PEO-silane amphiphiles in marine 
silicone coatings will continue to be explored. 
With a methacrylate crosslinking group (Figure 5.1), these SMAs could also be 
incorporated into UV-cure hydrogel materials for a variety of potential benefits, 
including protein resistance. Tear protein accumulation is considered a major reason for 
soft contact lens discontinuation as it causes discomfort and reduced visual acuity [273-
280]. Protein deposits additionally provide sites for bacterial attachment [281, 282] and 
are believed to cause giant papillary conjunctivitis [283, 284]. There is also a demand for 
contact lenses with enhanced oxygen permeability which can be accomplished by 
incorporation of silicone [285]. Unfortunately, it is difficult to incorporate silicone into 
hydrogels without increasing protein adsorption due to its hydrophobicity [285, 286]. As 
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 the diblock amphiphiles contain silicone (ODMS) complexed with PEO, it may possible 
to incorporate them into contact lens hydrogels to simultaneously enhance both protein 
resistance and oxygen permeability. Furthermore, the presence of the free-end chains 
throughout the hydrogel bulk would resemble a loosely crosslinked second network and 
may therefore impart similar benefits to the bulk mechanical properties [287]. For this 
work, model contact lens hydrogel materials will be prepared with and without 
methacrylate-functionalized diblock amphiphiles and evaluated for protein resistance, 
oxygen permeability, and mechanical strength. 
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 APPENDIX 
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1H NMR of tri(ethylene oxide) allyl methyl ether (allyl methyl PEO3) [From Chapter II] 
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1H NMR of poly(ethylene oxide)8 allyl methyl ether (allyl methyl PEO8) [From Chapter 
II] 
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1H NMR of poly(ethylene oxide)16 allyl methyl ether (allyl methyl PEO16) [From 
Chapter II] 
 
 
 
O Si O SiSi H
13
(CH3CH2O)3Si X
X
BA
E
C
D
E’
E’
E
B
A
C+D
 
1H NMR of triethoxysilylethyl-polydimethylsiloxane13 (siloxane-control) [From 
Chapter II] 
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1H NMR of triethoxysilylpropyl-PEO3 (n = 3 PEO-control) [From Chapter II] 
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1H NMR of triethoxysilylpropyl-PEO8 (n = 8 PEO-control) [From Chapter II] 
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1H NMR of triethoxysilylpropyl-PEO16 (n = 16 PEO-control) [From Chapter II] 
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1H NMR of triethoxysilylethyl-polydimethylsiloxane13-block-PEO3 (n = 3 PEO-silane 
amphiphile) [From Chapter II and III] 
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1H NMR of triethoxysilylethyl-polydimethylsiloxane13-block-PEO8 (n = 8, m = 13 PEO-
silane amphiphile) [From Chapter II, III and IV] 
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1H NMR of triethoxysilylethyl-polydimethylsiloxane13-block-PEO16 (n = 16 PEO-silane 
amphiphile) [From Chapter II and III] 
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1H NMR of triethoxysilylethyl-polydimethylsiloxane30-block-PEO8 (m = 30 PEO-silane 
amphiphile) [From Chapter IV] 
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1H NMR of PEO8-block-polydimethylsiloxane13 (m = 13 diblock SMA) [From Chapter 
IV] 
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1H NMR of PEO8-block-polydimethylsiloxane30 (m = 30 diblock SMA) [From Chapter 
IV] 
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1H NMR of PEO8-block-polydimethylsiloxane13-block-PEO8 (m = 13 triblock SMA) 
[From Chapter IV] 
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1H NMR of PEO8-block-polydimethylsiloxane30-block-PEO8 (m = 30 triblock SMA) 
[From Chapter IV] 
 
 
 
Synthesis of Methacrylate-Functionalized PDMS-block-PEO 
PEO-block-PDMS copolymers were functionalized by addition of allyl 
methacrylate using Karstedt’s-catalyzed hydrosilylation. Diblock SMA (m = 13, from 
Chapter IV) (5.00 g, 3.29 mmol) and allyl methacrylate (0.84 g, 6.67 mmol) (1:2 molar 
ratio), hydroquinone (0.01 g), and Karstedt’s catalyst (10 µL) were reacted in a 25 mL 
pressure tube with 6 mL dry toluene. A Teflon-coated stir bar was added to agitate the 
mixture and the tube was purged with N2 gas before sealing and heating in an oil bath set 
to 60 °C. After 6 h, the reaction was removed from heat and volatiles removed under 
reduced pressure. Chemical structure was confirmed with NMR spectroscopy using a 
Mercury 300 MHz spectrometer operating in the Fourier transform mode and using 
CDCl3 as the standard. 1H NMR (δ, ppm): -0.01–0.12 (m, 90H, SiCH3), 0.47–0.60 (m, 
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 4H, SiCH2), 1.52–1.76 (m, 4H, CH2CH2CH2), 1.90–1.97 (m, 3H, CCH3), 3.38 (s, 3H, 
OCH3), 3.41 (t, J = 7.1 Hz, 2H, SiCH2CH2CH2OCH2), 3.52–3.73 (m, 32H, OCH2CH2O), 
4.10 (t, J = 6.9 Hz, 2H, SiCH2CH2CH2OC), 5.52–5.68 (m, 1H, CCH2), and 6.09–6.21 
(m, 1H, CCH2). 
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1H NMR of PEO8-block-polydimethylsiloxane30-propylmethacrylate [From Chapter V] 
 
137 
 
